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SUMMARY
Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI)
is one of several proteomics technologies that can be used in biomarker discovery studies.
Such studies often have the goal of finding protein markers that predict early onset of can-
cers such as cervical cancer. The reproducibility of SELDI has been shown to be an issue
in the literature. There are numerous sources of error in a SELDI experiment starting with
sample collection from patients to the signal processing steps used to estimate the protein
mass and abundance values present in a sample.
This dissertation is concerned with all aspects of signal processing related to SELDI’s
use in biomarker discovery projects. In chapter 2, we perform a comprehensive study of the
most popular preprocessing algorithms available. Next, in chapter 3, we study the basic
statistics of SELDI data acquisition. From here, we propose a quadratic variance measure-
ment model for buffer+matrix only spectra. This model leads us to develop a modified
Antoniadis-Sapatinas wavelet denoising algorithm that demonstrates superior performance
when compared to MassSpecWavelet, one of the leading techniques for preprocessing SELDI
data. In chapter 4, we show that the quadratic variance model 1) extends to real pooled
cervical mucus QC data from a clinical study, 2) predicts behavior and reproducibility of
peak heights, and 3) finds four times as many reproducible peaks as the vendor-supplied
preprocessing programs.
The quadratic variance measurement model for SELDI data is fundamental and promises




INTRODUCTION - PROTEOMICS AND BIOMARKER DISCOVERY
1.1 Introduction
Mass spectrometry is one of the more promising tools for solving the fundamental proteomics
problem of studying expression levels of proteins in organisms. Proteomics, the study of
the complete set of proteins in a living organism, promises to solve many open problems in
medicine and public health in the 21st century.
In collaboration with the Centers for Disease Control and Prevention (CDC) in At-
lanta, GA, we investigate the capability of high-throughput surface-enhanced laser desorp-
tion/ionization (SELDI) time-of-flight (TOF) mass spectrometers (MS) for solving the fun-
damental proteomics problem. While the SELDI-TOF MS platform does not have the best
mass accuracy, sensitivity, and resolution properties compared to other mass spectrome-
ters, its price/performance ratio makes it an attractive tool for high throughput hypothesis
generating studies. Additionally, its automated chip chemistry technology enables high
throughput analysis of hundreds of spectra per day, a significant virtue.
When receiving raw spectra returns from the SELDI-TOF MS, there are numerous
computational steps that need to be performed to process the data to detect the mass/charge
(m/z) of the proteins present in the sample and then to extract estimates of their expression
levels. These processing steps typically include
• Calibration,






For each of these processing steps, there are many possible ways to proceed. One of the
major difficulties is that there is significant interaction between the processing steps. This
means that a failure in one of those steps can corrupt the SELDI-TOF MS signal and bias
the interpretation of the entire experiment. Currently, many scientists are struggling to sort
through the many choices of software packages that perform these processing steps using
a wide array of different approaches. This is a source of confusion and a bottleneck for
scientific discovery for investigators at the CDC, who are using SELDI-TOF MS to study
the pathogenesis of various diseases.
1.2 The Fundamental Proteomics Problem
The field of proteomics promises to revolutionize the diagnosis and treatment of diseases in
the 21st century. One interesting case study is the early diagnosis of cancer. It turns out
that most cancer patients are diagnosed in the late stage. For example, [42, 50] point out
that 72% of lung, 57% of colorectal, and 34% of breast cancer patients are diagnosed in the
late stage. Late-stage diagnosis can often lead to fatality. However, the survival rate is 85%
for cancer patients who have been diagnosed in the early-stage. The proteomics approach
to this problem is to study the proteins present in easily accessible fluids such as urine,
serum, plasma, and mucus to identify biomarkers that may be used to detect the onset of
the disease in the early stage. The idea is that proteins active in the cells of organs filter
into these fluids, especially serum and plasma, enabling a medium for accessible monitoring
of organ function.
We now introduce the mathematical formulation of the fundamental proteomics prob-
lem. In the fundamental proteomics problem, we have NC early stage cancer patients and
NH healthy patients (the control group). For each patient, we observe the activity level
(called expression level) of P proteins of interest. We can summarize our observations with
two matrices. First we have the P × NH matrix XH , with the (i, j)th entry containing
the expression level of the ith protein in the jth healthy patient. Similarly, we can group
the measurements from the cancer patients into a matrix denoted as XC . The matrices
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XC , XH are sometimes referred to as peak expression matrices [21], analogous to the mi-
croarray data analysis problem. From the clinical data, {XC , XH}, we wish to infer a
prediction function g : RP 7→ {C,H} such that when we take the corresponding protein
expression level measurements of a new patient x• = (x1, . . . , xP ), we can produce a quality
diagnosis g(x•;XC , XH). The essential properties of g are
• high prediction accuracy and ability to generalize well to the population;
• ability to identify several proteins that are the most important indicators.
While, for clarity of formulation, we have described one of the patient groups as cancer
patients, this formulation is by no means restricted to this setting and in fact is very general,
encompassing a large number of proteomics problems of interest to clinicians.
Within the framework of the fundamental proteomics problem, a relevant and important
scientific problem is that of how to decide which P proteins are interesting and how to
measure their corresponding expression levels. There are many possibilities for measuring
expression levels, but the two most promising approaches that have been under active
development in the last decade are DNA microarrays [105] and mass spectrometry [101]
techniques. The SELDI-TOF MS platform is one type of mass spectrometer that is used in
the framework of the fundamental proteomics problem. When SELDI-TOF MS or matrix-
assisted laser desorption/ionization TOF MS is used to study proteins as stated in the
fundamental proteomics problem it is often referred to as protein profiling.
1.3 SELDI-TOF Mass Spectrometry
1.3.1 Motivation for using time-of-flight analysis
Currently there is no standard mass spectrometer that is the universal solution to all possible
investigations under the umbrella of the fundamental proteomics problem. There are many
different architectures of mass spectrometers, with each design presenting a trade-off in
mass accuracy, resolving power, sensitivity, and dynamic range (see [32, 101, 122] for an
overview). MS platforms also vary significantly in their cost and throughput abilities. The
scientific staff at the CDC is interested in the SELDI-TOF MS platform for the following
reasons:
3
1. Robot-automated sample preparation,
2. High-throughput capability (hundreds of spectra produced per day),
3. Convenient size,
4. Reasonable price/performance ratio.
These virtues give SELDI-TOF MS the potential for future clinical deployment with further
advancements. SELDI-TOF mass spectrometers are essentially a variant of matrix-assisted
laser desorption and ionization time-of-flight (MALDI-TOF) mass spectrometers, which
were pioneered by [66, 107]. Tanaka [107] shared the Nobel Prize for chemistry in 2002 for
this ground-breaking work on laser-based soft ionization techniques. The principal difference
is that SELDI-TOF mass spectrometers use proprietary chip chemistry to bind specifically
to proteins with certain chemical/physical properties to achieve sample complexity reduc-
tion [46]. Further, SELDI-TOF MS has a shorter flight tube than most MALDI-TOF MS
machines, which results in poorer resolving power. However, this trade-off allows SELDI-
TOF MS to be of reasonable geometric size with the potential to be deployed in a clinical
setting.
1.3.2 Physical Principles of SELDI-TOF Mass Spectrometry
Here, we present an overview of the sample preparation procedure and physics that enable
SELDI-TOF MS to be used for protein profiling. For additional details, see [46]. First,
the biological sample of interest is applied to the proprietary ProteinChip array that binds
proteins with specific physical/chemical properties. Next, proteins that have not bound
or have bound weakly are washed away from the chip, leaving only the desired analytes.
The sample is then crystallized within an energy-absorbing matrix, typically sinapinnic
acid, as shown in Figure 11. Note that these steps are all fully automated for SELDI-
TOF MS when integrated with the Biomek 3000 package (but not necessarily automated
with other mass spectrometry platforms). At this stage, the preprocessing of the sample
is complete and it is placed into the sample inlet of the SELDI-TOF mass spectrometer.
1http://urology.jhu.edu/research/img/proteomics13.jpg
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Figure 1: Overview of SELDI-TOF MS sample preparation procedure.
Figure 2: Schematic of MALDI/SELDI mass spectrometry platforms.
A schematic representation of the MALDI-TOF/SELDI-TOF style mass spectrometer is
shown in Figure 22. In the MS, a laser is fired at the sample. Upon impact, the matrix
absorbs most of the laser’s energy, while the protein mixture is both ionized via proton-
donation and desorbed from the sample plate into a gaseous state [101]. The remarkable
breakthrough in MALDI/SELDI techniques is that most of the protein mixture survives
the desorption process intact. Once desorbed, the ions are accelerated through the source
extraction region (shown in red in Figure 2) using static electric fields. In principle, all
ions have the same kinetic energy as they enter the field-free drift region. Here, the smaller
2http://www.psrc.usm.edu/mauritz/images/maldi1b.jpg
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ions move quickly toward the detector, while the larger proteins take longer to arrive. For
time-lag focusing time-of-flight mass spectrometers, the amount of time it takes to reach the




















In (1), m is the mass of the ion, z is the corresponding charge (often 1 eV), d is the length
of the drift region, and s0 (s1) are the lengths of the first (second) stages of the extraction
region with corresponding electric fields E0 (E1). Typically the length of the drift region


















Although we theoretically know all the terms in (2) except the m/z, in practice a calibration
step is performed by first running a sample containing proteins/peptides of known mass and
fitting the constants a, b in (3). For a fixed t, the detector outputs a corresponding intensity
value that is roughly proportional to the relative abundance of ions colliding with the
detector at time t. Four example SELDI-TOF mass spectra are shown in Figure 3.
1.3.3 Applications of SELDI-TOF MS
The breadth of proteomics-based studies attempted by scientists using the SELDI-TOF MS
platform is impressive. Table 1 contains a non-exhaustive list of proteomics applications
of SELDI, illustrating the broad reach of mass spectrometry within the framework of the
fundamental proteomics problem to solve many problems related to biology, medicine, and
public health. The ovarian cancer study by [90] was one of the very early SELDI studies
conducted for early detection of cancer. In their paper, the authors predicted a biomarker
6
.
Figure 3: SELDI-TOF MS spectra of blood serum. The x axis is m/z, while the y axis is
intensity.
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Table 1: Proteomics applications of SELDI-TOF mass spectrometry.
Cancer Studies
Breast [20,67,89,93,134]











Rat Liver Cirrhosis [128,134]
Schizophrenia [83]
Bipolar Disorder [83]
Arsenic and Lead Poisoning [133]
Rheumatoid Arthritis [26]
Idiopathic Nephrotic Syndrome [126]
for early detection that later led to widespread optimism about the capability of the SELDI-
TOF MS platform. As will be discussed in Section 1.4, Baggerly and colleagues at the MD
Anderson Cancer Center were able to find flaws in the study [5]. Other studies that have
received considerable attention in the SELDI community are the prostate cancer study by
Adam et al. [1] and the breast cancer study by [20].
This brief introduction to SELDI-TOF mass spectrometry is by no means comprehen-
sive. For a deeper discussion of the principles of time-of-flight mass spectrometry, see [23].
For other introductory texts on mass spectrometry, see [52,116]. It is worth mentioning that
tandem mass spectrometry (MS/MS), a technique that combines two mass spectrometers
in tandem, is an especially active area of research. MS/MS techniques allow researchers
to see a more detailed picture of activity, such as post-translational modifications, modu-
lating protein activity in the cell. For a review of some alternative approaches to protein
profiling based on MALDI/SELDI, see [32, 55, 104]. Now that we have been introduced to
SELDI-TOF MS, we are ready to proceed to the challenging preprocessing steps that must
be performed to use this technology effectively.
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1.4 Survey of Current Processing Techniques
The key criticism of one of the early major studies performed with SELDI [90] was that
an apparent aberration in the preprocessing techniques used by the authors resulted in
a significant non-biologically-based bias in the data that explained their ability to predict
ovarian cancer patients from healthy patients successfully [5]. The lesson to be learned from
this case study is clear: The preprocessing techniques used to remove noise and artifacts
from the data are of essential importance and can potentially ruin the conclusions of an
investigation. This served as the motivation for developing several alternatives to the Ci-
phergen ProteinChip/Express preprocessing suite [46] typically purchased with Ciphergen’s
proprietary SELDI-TOF mass spectrometers. An overview of some of these techniques is
presented in this section.
We previously listed the preprocessing steps necessary in Section 1.1. The reason each
step is needed will now be made clear, and a brief discussion of existing techniques published
for each step will be given.
1.4.1 Calibration
Calibration is needed to account for the practical reality that experiments are run on dif-
ferent days. While care is taken to reproduce all machine settings and sample preparation
steps exactly, there is a need to periodically fit machine parameters to a standard sample
of known proteins to ensure quality of experimental results.
We have derived a basic form of the calibration equation (3). The Ciphergen vendor-
supplied calibration technique adds an additional degree of freedom and considers a cali-
bration equation of the form
m/z
U
= a(t− t0)2 + b (4)
where we fit the parameters a, b, t0 in the usual least-squares way, and U represents a known
voltage setting [62]. There are more sophisticated ways of calibrating the SELDI-TOF MS
instrument, and we will briefly highlight a few.
Juhasz and colleagues suggest a correction technique after fitting the standard calibra-
tion model (3) to the data. Their method includes higher-order terms, m/z, (m/z)3/2, with
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accompanying parameters estimated by prior knowledge about the distribution of the initial
ion velocity off the matrix [64]. Acquiring this knowledge for a particular sample in question
requires additional experimental steps. Christian takes this idea and suggests expanding
(1) in an infinite series and keeping high-order terms. Then, this higher-order calibration
equation is solved using simplex optimization techniques [16].
Rather than drop terms as we did from (1) to (2), Hack and Benner model the residual
of the calibrants using a polynomial and use the model of the residual to refine the accuracy
of the calibration step [53]. However, one could argue their result to be dubious since they
only have five data points to fit in their paper. Bantscheff expands this idea by fitting
the residuals (mass errors) of 1800 peptides with a seventh order polynomial, using this
to refine the estimates of m/z given by the standard calibration equation [6]. Gobom also
uses a similar principle [51]. For the situation when large datasets are being generated,
Wolski proposes a way to do calibration without a specified calibration run through the
mass spectrometer [123].
Calibration, while very important, is relatively straightforward to carry out. We will
see later that the focus of our research efforts should in fact lie elsewhere.
1.4.2 Noise Filtering
SELDI-TOF MS data contains an additive noise component just like many other applica-
tions. However, the statistics of the noise processes inherent in SELDI data have not been
quantitatively well characterized in the literature. Observing Figure 3, one can propose a
reasonable model for raw SELDI data of the form
y(t) = b(t) + s(t) + w(t), (5)
where y(t) is the observed intensity at time-of-flight t, b(t) is a slow varying baseline effect
from the matrix, s(t) is the desired signal (consisting of peaks), and w(t) is an additive
noise component accounting for noise in the detector electronics. This sort of model has
been suggested by [82]. Noise filtering techniques seek to remove the w(t) component.
One approach to removing noise in SELDI data is through the use of linear time-invariant
(LTI) filters. In particular, the use of moving average filters and other low-pass filters has
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been proposed [46, 49, 72, 75]. Since mass spectrometry data is spiky in nature (and the
high-frequency peaks represent important information), this approach is probably not a
good idea.
Other approaches include local regression techniques such as the Savitzky-Golay filter
[98,124]. Bhanot and colleagues use a kernel smoother with a Guassian kernel [9].
Another popular approach for denoising SELDI spectra is using the wavelet transform.
In [21, 82], the authors use the undecimated discrete wavelet transform, while [35] applies
the continuous wavelet transform on a grid of informative scales and translations.
1.4.3 Baseline Correction
Baseline correction techniques seek to remove the slowly varying baseline b(t), characterized
by a sharp increase at low m/z followed by a gradual decay to a constant level, as seen
in Figure 3. Removal of the baseline is important for the accurate estimation of protein
expression levels for proteins with m/z less than 10,000 Da. Almost every approach first
tries to estimate b(t), and then subtract the corresponding estimate from the observed signal
y(t). Typically baseline removal is performed after noise filtering.
To estimate b(t), the Ciphergen software [46] uses a convex hull algorithm to estimate
the baseline signal as a piecewise linear function. Baggerly and colleagues [4] propose
subtracting locally the median or mean of intensities in a window and also allude to the
semi-monotonic baseline approach used later in [20, 21]. Sauve and Speed suggest using
the top-hat operator from mathematical morphology for baseline removal [97]. Another
approach is to fit a loess curve through all the local minima to estimate the baseline, which
is carried out by [108]. Andrade and Manolakos [2] use Guassian mixture models for the
data in a small window, essentially using the mean of the Guassian that is smaller as the
estimate of the baseline. Ressom et al. [95] use a spline to regress the baseline in a sliding
window.
One particularly unique approach to the problem is given by [72]. The authors propose
a charge-accumulation model for the baseline and invert it to subtract the baseline. This is
the only study that attempts to model the baseline in terms of the physics of the phenomena,
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although the theoretical justification for this model is unclear.
1.4.4 Peak Detection
Finding peaks in SELDI spectra is a critical processing step, as the location of the peak
reflects the average mass of the corresponding ion that was detected [101]. At the peak-
finding step, we assume that both the baseline and noise components of the SELDI-TOF MS
signal have been removed, leaving us with an estimate for s(t), the signature of the proteins
in our sample. Peak detection is a general problem encountered in many disciplines. Almost
all peak-finding methods contain two parts: finding all local maxima and performing a
thresholding test.
Detecting the local maxima is the simplest part of this process. One possible approach
is to take a point t to be a peak if y(t) is the largest value in a window [t− ε, t + ε]. Such
an approach forms the core of [9, 49, 108, 110, 131]. Alternatively, one can take the first
difference signal y′(t) = y(t + 1) − y(t) (assuming t = 1, . . . are discrete) and look for zero
crossings. Obviously, if one checks the sign of y′(t) before and after the zero crossing, the
location of all maxima becomes evident. This strategy is used by [18,82].
Most of the sophistication in peak finding goes into the calculation of a good threshold
test to discriminate a peak that is likely a good signal peak from a spurious peak from the
additive noise process. Assuming the noise component is additive white Guassian noise, the
best way to do this is to use a matched filter (matched to the shape of the peak) and then
apply a threshold to the output [92]. Unfortunately, the statistics of the noise process are
non-stationary and non-Guassian, and the shape of the peak is dependent on the resolution
of the machine at m/z of interest, the isotopic distribution of the protein at this m/z, and
the charge of the protein [101]. All of these factors are unknown to us a priori; thus heuristic
threshold tests are used.
We present briefly the peak-detection scheme used in caMassClass [110] to give the flavor
of approaches used for SELDI-TOF MS data. The package caMassClass declares a peak at
t if
1. y(t) is a local maximum in a window,
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2. The moving average filtered version of y evaluated at t is greater than a threshold,
3. A locally calculated z-score is greater than a threshold.
The user must set the size of the window to be used for the moving average filter, the size
of the window used for noise statistic estimates, the intensity quantile threshold, and the
z-score cutoff. This is a considerable parameter space to search, especially if large numbers
of spectra are to be processed.
Some techniques attempt to combine both peak detection and signal estimation/thresholding
into one step. For example, in chromatography, Vivo-Truyols and colleagues use the
Savitzky-Golay filter in a window and declare the maximum a peak if the second derivative
indicates sufficient concavity [112, 113]. Du and Lin perform their peak detection in the
wavelet domain and look for “ridge lines,” or peaks that occur at the same location across
many scales, as an indicator of a peak [35].
There are some references in the IEEE literature that address the peak-detection prob-
lem as well, such as [44,63]. However, the ideas on how to proceed are quite similar to those
already discussed.
1.4.5 Normalization
Once we have a set of m/z values corresponding to peaks (proteins), we wish to make
estimates of the expression levels (intensities). Normalization is an important step in this
process, as it removes bias created from variations in the amount of sample put into the
SELDI-TOF MS before analysis. Typically we are interested in processing a group of spectra
assumed to be generated from the same underlying distribution (e.g., as in the fundamental
proteomics problem mentioned in Sec. 1.2). Accounting for several spectra, we need to
adjust our model (5) to account for variations in the absolute quantity of proteins that
generated each spectrum:
yi(t) = bi(t) + Mis(t) + wi(t), i = 1, . . . , NH or C . (6)
In (6), bi(t) accounts for differences in baseline trends per spectrum, wi(t) represents differ-
ent sample paths of the detector noise process (all assumed to be uncorrelated from each
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other), and Mi is a scalar factor that accounts for different absolute levels of protein sam-
ple delivered to the MS. Note that (6) assumes that relative abundances of the individual
proteins in each sample are the same for all i. Normalization techniques seek to remove the
effect of Mi.
Suppose we have removed the baseline signal from all of the spectra in (6). This leaves
us with
ŷi(t) ≈ Mis(t) + wi(t). (7)
Integrating (7) with respect to all of our observations, we see that∫
ŷi(t)dt ≈ cMi, (8)
where we have assumed that the noise processes wi(t) are zero mean, mean-ergodic random
processes [88]. Under these assumptions, it is clear from this development that we can





where ω is a constant factor we are free to choose. This approach to normalization is called
total ion current (TIC) normalization [46]. Dudoit et al. [36] investigated the usefulness
of TIC normalization and have preliminary results confirming its utility in SELDI data
analysis. Other authors [4, 21, 82] also use the TIC method for quantification. Ressom et
al. [95] also use TIC normalization, additionally choosing ω so that the maximum intensity
across all spectra is equal to 100.
Alternatives to TIC have also been proposed. In particular, Tibshirani et al. [108]
linearly map the 10th and 90th percentiles for each spectra to 0 and 1, respectively. A
less robust variant of the Tibshirani approach is used in [9]. Carlson et al. [12] proposes
a normalization technique similar to an approach used in microarray normalization. First,
they focus on several peaks that have large intensity consistently across spectra. Then
they use an EM algorithm to estimate the scale factors Mi. They compare their approach
to TIC normalization and suggest that the TIC method introduces significant bias. In
[130],the authors use the TIC method but first they insist on transforming the intensities
by a logarithmic transformation.
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1.4.6 Peak Alignment
Peak-alignment algorithms seek to correct for variation in the t (or equivalently m/z)
value registered at the detector for the same protein. For example, if we were to run
10 pure samples of the protein hemoglobin on 10 consecutive days, we would find that the
m/z values detected on those 10 days would be slightly different. This is also evident in
Figure 3. In these four example spectra, there is a protein represented with a peak at
33091.70, 33089.10, 33083.10, and 33062.00 Daltons respectively. While these four m/z val-
ues are all different, they represent a protein with the same underlying m/z in this case.
There are many factors that go into this, but the most important one is the frequency of
calibration runs in the SELDI-TOF MS. Now, imagine we have 100 spectra generated from
the same sample, each with 100−200 peak predictions! Most m/z values in this master list
will be unique because of the calibration error. Now, since in the fundamental proteomics
problem we wish to find P proteins of interest, we need an algorithm to look at the peak
predictions on all 100 spectra and produce a list of m/z values that indicate average loca-
tions of proteins that are interesting in the sample. The goal of peak alignment is exactly
this.
The simplest way to tackle this problem is to interpolate all the spectra onto the same
t grid and then perform peak detection on the mean spectrum. This was suggested by
[82], and this is also suggested in the documentation for PROcess [49]. Using the mean
spectrum in this way has the possibility of eliminating peaks with low expression levels,
however. Summarizing briefly, other approaches use hierarchical clustering [108], dynamic
programming [97], cross correlation analysis [72, 124, 125], quadratic or cubic splines [62],
and interval masking [20,130,131].
1.5 The Fundamental Paradox of SELDI-TOF MS Protein Profiling
In Section 1.3.3, we mentioned several early studies [1,90] that led to widespread optimism
about the use of SELDI-TOF MS as the right platform for solving the fundamental pro-
teomics problem. We also mentioned that [5] pointed out inconsistencies in the data in [90]
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because of failures in the processing of the samples and the implementation of the data anal-
ysis steps described in Section 1.4. This led to increased scrutiny and criticism [13,27–30,85]
of studies that were using SELDI-TOF MS. The implications of these studies and accompa-
nying papers criticizing them were clear: it is essential to be especially careful when selecting
the parameters for the preprocessing steps described in Section 1.4 to ensure high-quality
estimation of the P proteins of interest and their expression levels.
Recalling the formulation from the fundamental proteomics problem described in Sec-
tion 1.2, we are interested in analyzing NH spectra from our healthy patients and NC
spectra from the cancer group. If NH and NC are very small, then it’s possible for an ex-
pert chemist/clinician to do the peak calling and peak alignment practically manually. To
estimate the expression levels, the clinician could take an iterative approach, trying differ-
ent parameter settings for baseline removal and smoothing until the result was satisfactory
by his/her expert opinion. This is the most straightforward way to produce a high-quality
result that avoids the sort of criticism that was alluded to in the beginning of this section.
Typically, for samples generated from blood serum, the number of proteins of interest
that clinicians are interested in keeping track of is in the ballpark of P ≥ 50. In the lingo of
statistical pattern recognition, this means that the dimension of our feature space is at least
50. It is a well-known result, called the curse of dimensionality, that as the dimension of the
feature space increases, the number of training samples needed to develop a good prediction
rule increases exponentially [54]. For example, consider the case when we constrain ourselves
to only look at the expression levels of one protein. Now, suppose we consider measuring
the expression level of 10 samples of this protein to be a sufficiently dense sampling of
expression levels. To get an equivalently good representation of the behavior of 50 proteins,
which may be interacting with each other, we would need 1050 samples (adapted from an
example in [54]). Thus, since the dimension of our feature space is high, we need NH  P ,
NC  P samples. This is just the beginning. Suppose we generate three replicates per
patient, with each replicate undergoing a six fold fractionation step, and suppose we are
performing a detailed study of cancer with five subtypes and three progressive stages of
interest. In this scenario, which is closer to the approach desired by laboratory scientists,
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we have compounded the number of classes we are studying by adding fractionation and
subtypes and stages of cancer. If we choose to target P = 50 proteins of interest for this
problem and choose 100 samples for each class to be sufficient for learning the classification
rule, then we would be generating 5 · 3 · 6 · 3 · 100 = 27, 000 spectra total that need to be
preprocessed to estimate the P proteins of interest and their expression levels!
Currently, no algorithm/software package available has established an ability to prepro-
cess 27, 000 spectra in a fully automated fashion such that it will avoid adding significant
bias into the data and repeat the pitfalls of studies such as [90]. To summarize, the scien-
tific community faces a great paradox in the application of SELDI-TOF MS as a candidate
solution to the fundamental proteomics problem:
The Fundamental Paradox
• For high-quality, reproducible preprocessing of SELDI-TOF MS spectra we need to
keep NH and NC small to allow for a large amount of expert intervention in the
processing steps
• To estimate an accurate decision rule g discriminating cancer from healthy patients,
we need to have NH and NC be as large as possible to minimize the effect of the curse
of dimensionality and prevent over-fitting the data. This in turn introduces significant
bias in the data because of the inconsistent quality of current preprocessing algorithms.
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CHAPTER II
BENCHMARKING CURRENTLY AVAILABLE SELDI-TOF MS
PREPROCESSING TECHNIQUES
2.1 Abstract
Motivation: SELDI protein profiling experiments can be used as a first step in studying the
pathogenesis of various diseases such as cancer. There are a plethora of software packages
available for doing the preprocessing of SELDI data, each with many options and written
from different signal processing perspectives, offering many researchers choices they may
not have the background or desire to make. Moreover, several studies have shown that
mistakes in the preprocessing of the data can bias the biological interpretation of the study.
For this reason, we conduct the first large scale evaluation of available signal processing
techniques to establish which are most effective. We use data generated from a standard,
published simulation engine so that “truth” is known.
Conclusions: We select the top algorithms by considering two logical performance
metrics, and give our recommendations for research directions that are likely to be most
promising. There is considerable opportunity for future contributions improving the signal
processing of SELDI spectra.
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2.2 Introduction
Mass spectrometry continues to be aggressively pursued as a promising tool for disease
biomarker discovery. Currently, there are many possible mass spectrometry platforms one
could choose from such as SELDI-TOF, MALDI-TOF, FT-ICR, Ion Traps, Orbitraps, and
other popular platforms (reviewed in [32]). Among the many choices available, some biolo-
gists have turned to SELDI-TOF MS for two principal reasons:
1. Robot-automated sample preparation using the Biomek R© 2000 system,
2. High throughput generation of hundreds of spectra per day.
Early work with SELDI-TOF MS in 2002 produced biomarker predictions and diagnos-
tics for ovarian cancer [90], prostate cancer [1, 94], and led to considerable optimism about
the utility of this platform [60,61,121,127].
With increased excitement came increased scrutiny, and in particular, scrutiny of the
ground breaking ovarian cancer study by Petricoin and colleagues [90]. After careful ex-
amination of the data independently by Sorace and Zhan [103] and Baggerly et al. [5],
both studies found systematic biases in the data that explained the ability to classify can-
cer from normal. Some of the key conclusions from [5] indicated problems with baseline
correction, inconsistencies in sample preparation techniques used, calibration, feature de-
tection (reproducibility of protein m/z values detected), and noise processes changing in the
dataset. This in turn raised alarms throughout the scientific community, leading to numer-
ous articles criticizing SELDI-TOF MS protein profiling [13,27–30,85]. While these articles
criticizing SELDI may have deterred some researchers, others saw this as a challenge to
make SELDI as reproducible and reliable as possible. Several labs addressed reproducibil-
ity of SELDI [38,100,120], most notably the Semmes’ lab at Eastern Virginia Medical School
(EVMS) [100]. Semmes has led a multi-institutional effort to establish protocols to ensure
minimum quality standards in the data.
In general there are seven computational steps that need to be performed to extract the
desired information from a SELDI-TOF experiment before classification techniques can be
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used to identify biomarker candidates. A comprehensive review of all the different possi-
bilities for each preprocessing step is beyond the scope of this paper. For a light overview
of why each of the preprocessing steps are needed, see [91]. We show the typical signal
processing logic used in Figure 4. Recently, [80] showed that choice of the normalization
Figure 4: Typical preprocessing procedure for MALDI/SELDI protein profiling data.
step alone can have a significant effect on the quality of SELDI data, from the perspective
of both intra-class coefficient of variation and classification accuracy between disease and
non-disease classes. From the practicing clinician’s point of view, one would want to know
which available software package contains the “right” set of preprocessing techniques to
ensure the best quality and reproducibility in the data.
Beyer et al. [8] have compared two of the major preprocessing software suites. While
this was a good first step, the authors only compared two of the possible algorithms. There
are several papers proposing new algorithm suites, but in each case the authors choose to
compare their new algorithm to only one or two other algorithm, across different datasets
(e.g. - [35, 82]).
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We propose a significant comparison of the current techniques. In particular, we want to
know if any of these approaches show promise as an automated method to preprocess large
amounts of spectra reliably. We have carefully chosen among the most popular preprocessing
software suites that a practicing scientist would be likely to try out. Approximately half
of the programs we have chosen have been used in an applied SELDI study, indicating an
immediate need to know their performance capabilities. For example, Ciphergen Express
is used in [69] and numerous other studies, PPC in [17], Bioconductor PROcess in [11],
and caMassClass in [57]. For a description of our criteria for inclusion in the study, see the
supplementary info. The complete list of preprocessing packages we will be examining in
this study is shown in Table 2.
Recently, Cruz-Marcelo et al. [24] published a study comparing five algorithms, four of
which are included in this study [35,46,49,82]. They provided an analysis of peak detection
on simulated data, and peak quantification on real data using human control serum. In
their work, they found that the vendor supplied software, Ciphergen Express [46], performed
well. They also found that [35] and [82] were fairly adept at peak detection. One of their
recommendations is that multiple programs be used together to process the data ( [35] for
peak detection, and [49] for quantification). In this paper, we analyze nine algorithms, listed
in Table 2, with the goal to understand in greater detail the processing steps and their effect
on the critical task of peak detection. Specifically, we study how peak detection performance
may vary with protein mass, protein concentration, and consistency of occurrence in spectra.
We find that peak detection performance is highly dependent on mass, concentration, and
consistency of appearance. We also find that even the best algorithms leave considerable
room for improvement, especially below 10 kDa.
2.3 Materials and Methods
2.3.1 Datasets
Further complicating the comparison of algorithms’ performance is that on real SELDI data,
we do not actually know what truth is a priori. We may detect a peak at 5 kDa, but it is





















































































































































































































































































































































































introduced by the preprocessing steps, or a spurious peak due to the additive noise process
inherent in SELDI spectra. Because of this, we cannot say that algorithm A is better than
algorithm B just because A found a peak in some real data that B did not find.
Therefore, if we wish to make valid scientific conclusions about which preprocessing
algorithms show the most promise, we must compare them on data that we know the true
protein content of in advance of the experiments. One possibility is to use the calibration
samples (or spike-in data), that typically contain a small number of peptides (< 10) of
known m/z value. This approach was taken in [35, 106]. However, this approach does not
accurately reflect the complexity of the samples typically profiled with SELDI, which often
contain on the order of 100’s of proteins.
With this in mind, we conclude that the only reasonable way to compare the preprocess-
ing algorithms is by using a model of the dual stage delayed-extraction TOF architecture
typical of SELDI platforms. Fortunately, Coombes and colleagues have developed a low res-
olution MALDI/SELDI MS simulation engine from first principals [18, 82]. The principal
virtues of their simulation engine are:
1. It is based on the physical principles of the dual stage delayed-extraction MALDI
architecture
2. Simulation parameters are estimated from actual low resolution MALDI experiments
3. It allows for generating data from complex mixtures of virtual protein populations,
where we know the true protein m/z value at all times.
We use 100 different datasets representing samplings from the same population, with
each sampling containing 100 spectra to measure the algorithms against each other. The
data are available for download at http://bioinformatics.mdanderson.org/Supplements/
Datasets/Simulations/index.html. For detailed discussion of the simulation dataset, see
the supplementary information provided or [18,82].
Originally, [18, 82] proposed their simulated dataset be used as a benchmark for pre-
processing algorithms. In lieu of the discussion presented here, we agree and proceed with
their dataset for our comparisons.
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2.3.2 Performance Comparison
The goal for each algorithm in this study is to reconstruct the list of 150 protein m/z
values for each of the 100 datasets (sample populations). In order to assess performance
capabilities, we have run each of the algorithms over a wide range of parameter choices
as recommended by the developers of each package. For more information about how the
parameters were selected, see the supplementary information. For each parameter choice
on each dataset, we calculate the observed false discovery rate (FDR) and true positive rate









Similar to [82], we define the TP (the number of true positives) as the number of the 150
virtual protein m/z values having at least one predicted m/z value within 0.3% relative
error. The FP is defined as the number of predicted m/z values not within 0.3% of any
of the 150 virtual protein m/z values for this dataset. Similarly, FN is the number of the
150 virtual protein values without any predicted m/z value within 0.3% relative error. As
done in [82], we also keep track of predictions and proteins that match a multiple number
of times, represented by the quantities MM1 and MM2.
2.3.2.1 Operating Characteristics
One way to view the peak detection problem is as a special type of binary classification
problem [82]. From this perspective, a decision is made at each m/z value whether there
exists a virtual protein or not. Because of the huge number of hypotheses being tested,
this manifests itself as a multiple testing problem. In this scenario, the classic notion
of restricting type I error (e.g. - using Neyman-Pearson tests) is not quite as useful [7].
However, one certainly is concerned with the false-discovery rate, as defined in Eq. 10.
One of the best ways to understand the performance of a program is to look at the
trade-offs between sensitivity and false-discovery rate obtained by varying free parameters.
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From these empirically observed points, we use loess smoothing to estimate operating char-
acteristics (OC) for each program as a summary of its performance on each dataset. This is
similar to the receiver-operating characteristic [43], except the false-discovery rate has been
substituted for the type I error rate in our case. Other authors have reported similar oper-
ating characteristics in their work as well [35,82,106]. This multiple testing problem, along
with the use of operating characteristics to address it have been used in the microarray
analysis literature also [15].
We wrote numerous scripts to automatically evaluate each program over a wide range of
parameter combinations. The simulations benchmarking the algorithms consumed approx-
imately a year of computing time, spread across several cores in a small computing cluster.
For the purposes of evaluating the performance of preprocessing programs for SELDI, we
have developed our own software toolbox, written in Matlab, and provided as supplemen-
tary information. Unfortunately, there is no built-in scripting capability for the Ciphergen
Express program. Thus we had to perform analysis with Ciphergen by hand, which was
rather laborious. As a result, the Ciphergen Express program contains less operating points
and we used a piecewise linear representation of its operating characteristic rather than a
loess smoothed one.
2.3.2.2 Metrics for Ranking Algorithms
We propose two principal figures of merit for the purpose of ranking the algorithms from
most to least promising. While we are most interested in average performance across the
100 datasets, we do report the standard error as well. Indeed, it would not be a good result
if performance varied significantly for different samplings from the same population, as in
our simulation set up. We define each metric first, with explanations to follow.





2. PAUC (Partial Area Under the Curve): For each dataset, calculate the area under the
OC curve between FDR values of 0% and 50%. PAUC is the average of this quantity
across all 100 datasets.
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The MEANTPR metric represents the sort of sensitivity that a practicing biologist is
likely to observe if they proceed by trying a few parameter choices in the range suggested
by the algorithm’s author and look at the result. In other words, MEANTPR reflects the
average percentage of real proteins that one would expect to find with the corresponding
method being evaluated.
In contrast to MEANTPR, the PAUC metric considers the well known trade-offs between
FDR and TPR that are typical when one varies parameters in a hypothesis testing setting.
Not all operating points on the OC curve are useful for applications of interest such as
biomarker discovery. For example, when a program is operating at a FDR of 50%, it
corresponds to the “coin flip” scenario: half of the predicted peak m/z values correspond
to true proteins, and half are erroneous, so that operating points with FDR ∈ (50%, 100%]
are not very useful. Because of this, we define our second benchmarking metric, the partial
area under the curve (PAUC), to be the the area under the OC curve over the domain
FDR ∈ [0%, 50%).
2.4 Results and Discussion
2.4.1 Global Ranking of the Algorithms
Using the metrics defined in Section 2.3.2.2, we have ranked the algorithms from most
promising to least, as illustrated in Tables 3 and 4. Because the MEANTPR metric relates
Table 3: Algorithm ranks using mean sensitivity (MEANTPR) as the figure of merit.
Rank Program Name Metric Score SEM
1 MassSpecWavelet [35] 51.5% 3.6%
2 PPC [108] 47.2% 3.0%
3 Ciphergen [46] 47.1% 5.3%
4 Mean Spectrum [82] 40.5% 3.1%
5 Cromwell [21] 28.7% 5.4%
6 GenePattern [75] 19.4% 2.1%
7 PROcess [49] 19.0% 1.9%
8 CaMassClass [110] 17.2% 2.1%
9 PROcess/Mean Spectrum [49] 6.1% 1.3%
closely to the way the data analysis usually proceeds in the lab, we place heavy emphasis
on the importance of the results in Table 3. Two algorithms, MassSpecWavelet [35] and
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Table 4: Algorithm ranks using partial area under the curve (PAUC) as the figure of merit.
Note, PPC was excluded since it had no observed operating points for FDR ∈ [0, 0.5).
Rank Program Name Metric Score SEM
1 Ciphergen [46] 0.284 0.07
2 Mean Spectrum [82] 0.280 0.05
3 CaMassClass [110] 0.279 0.03
4 MassSpecWavelet [35] 0.251 0.05
5 Cromwell [21] 0.206 0.05
6 GenePattern [75] 0.164 0.06
7 PROcess [49] 0.108 0.02
8 PROcess/Mean Spectrum [49] 0.086 0.09
PPC [108], stand out with mean sensitivities of 51.5% and 47.2% respectively.
With respect to PAUC measure, Ciphergen Express [46] and Mean Spectrum [82],
are the top two performers. Their corresponding operating characteristics, along with
MassSpecWavelet’s [35], are displayed in Figure 5. Operating characteristics for the rest of
the programs are given as supplementary information.
2.4.2 Potential for Identifying Special Classes of Proteins
While the results in the previous section present us with what seems to be the most promis-
ing algorithms, the practical question is whether these programs compliment each other
or are redundant. Most importantly, we wish to know what are the characteristics of the
virtual proteins found by each algorithm?
2.4.2.1 Dependence on Mass
We have assessed the mean sensitivity of the algorithms as a function of mass, in order
to identify regions of the m/z axis where algorithms tend to perform well or poorly. The
results of our analysis are summarized in Figure 6. Generally, the trend for all algorithms is
that MEANTPR increases with protein m/z. All algorithms experienced difficulties finding
the true protein m/z values for proteins less than about 6 kDa. This is rather unfortunate
news for the application of protein profiling to many disease investigations, as there may
be important small proteins that one may want to find here such as defensins (peptide
antimicrobials) in the 3 to 3.5 kDa range.
We have analyzed the effect of peak density (measured in peaks per Da) on the MEANTPR
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Figure 5: Operating characteristics for the top 3 programs (with respect to PAUC metric).
The solid line represents the mean operating characteristic, with the dashed lines indicating
the mean plus/minus the standard error.
observed for the algorithms. The results of this analysis are shown in Figure 7. Figure 7
(top) shows that in our simulation model the peaks tend to be more spread out at higher
at higher m/z values.
We have observed this to be true in typical blood serum spectra as well. We have further
noted a strong negative correlation between peak density and MEANTPR for three of the
top performing algorithms. Thus, in our opinion peak density is the true underlying cause
for the trends observed in Figure 6.
One may also wonder whether poor calibration may be affecting the performance of the
algorithms. The calibrant m/z values used in the study are shown as red dots in Figure
6 along the bottom. Clearly, the calibrants span the m/z range of nearly all protein m/z
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Figure 6: Mean sensitivity as a function of mass for each algorithm. Each mass bin was
specially selected in increments of 10% of the quantile function of all the pooled true protein
masses from all 100 datasets. The red dots on the x axis indicate the approximate m/z
values of the virtual protein standards used to fit the calibration equation (occurring at 1,
2, 5, 10, and 20 kDa).
values used in the simulation, thus we do not believe calibration contributes significantly
to our observations in Figure 6. However, calibration does certainly contribute to mass
error. In particular, relative mass errors of 0.34%, 0.17%, 0.07%, 0.05%, and 0.01% are
observed in single charged virtual proteins with molecular weights of 1, 2, 5, 10, and 20 kDa
respectively [19].
There is also evidence that the baseline contributes to biased estimates of the true
protein masses at very low m/z values. Figure 7 (top), shows that for the lowest m/z bin,
the peaks are not very dense. However, the corresponding MEANTPR for this point is 19%
(average over the three algorithms). This confirms our experience with SELDI. Namely,
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Relationship between meantpr, peak density, and mass of proteins in simulation study




















Figure 7: (top) Exploring density of peaks corresponding to proteins (measured in peaks
per Da) as a function of molecular mass in the simulation. Clearly, the peaks are more
densely packed at lower m/z values. The scale of the x axis is given in units of 104 Da.
(bottom) Density of proteins is a predictor of algorithm performance. The most dense areas
are at low mass, which partially explains why the algorithms performed so poorly in these
areas. Further, the abundant proteins also tend to occur at low Da, explaining why we have
observed decreased performance for increased abundance simulation parameter.
that there are few peaks appearing around 1100 Da, and that extracting good estimates of
the corresponding m/z values in this area are difficult due primarily to interference from the
baseline. In Figure 7 (bottom), we have removed this outlier for our corresponding analysis
due to the interference effect from the baseline and calibration at m/z around 1100 Da.
On the other hand, Figure 6 shows that, for proteins with a mass greater than about 7800
Da, MassSpecWavelet, Ciphergen Express, Mean Spectrum, and PPC are quite effective at
detecting them. This is good news, as there are numerous interesting proteins in this size
range.
We also uncovered an error in the way the isotope distribution is calculated for each
protein m/z value in the simulation engine, which results in a predictable bias in peak
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locations. After correspondence with Kevin Coombes of MD Anderson (one of the principal
authors of the simulation), the problem was promptly fixed in the current version of the
simulation engine available from their website. Since the additional mass error introduced
from this problem is typically small (on the order of 0.01 percent of mass) and presumably
does not favor any algorithm, we proceeded with the study [19].
2.4.2.2 Dependence on Prevalence
In the simulation model for SELDI data, protein prevalence is the probability that a virtual
protein appears in a spectrum. This models inherent randomness observed in SELDI data,
as it tends to be rare for a peak corresponding to a single protein to be observed in 100% of
the spectra in one’s data. We have investigated the effect of prevalence on the performance
of the algorithms, shown in Table 5. As expected, the mean sensitivity increases as protein
prevalence increases. This confirms intuition, as there are more chances of finding the
occurrence of this protein with higher prevalence. MassSpecWavelet [35] uniformly ranks
best for proteins of all classes of prevalence, and performs most uniformly with variations
in prevalence. This is potentially important, as low prevalence proteins may indicate the
presence of in important subgroup of samples within the dataset.
2.4.2.3 Prevalence and Abundance Interactions
Protein abundance is measured as the mean log intensity of the peaks corresponding to a
virtual protein in our model. This is related to the modeled protein concentration in the
virtual samples. It is estimated that protein concentrations in human cells easily span seven
to eight orders of magnitude, with speculation as high as twelve orders of magnitude [22].
Therefore, it is clearly of interest to understand how abundance and prevalence interact
and affect the performance of the algorithms investigated. Morris et al. conducted such
an investigation in [82]. However, they only looked at the performance of two algorithms,
namely [21,82].
We list the top two algorithms for each subclass of virtual proteins, along with their mean
sensitivities in Table 6. The table is organized so that each of the 9 cells contains results for
roughly the same number of peaks. Again, the performance of the MassSpecWavelet [35]
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algorithm is superior in all but the high prevalence/high abundance and medium preva-
lence/high abundance cases, which favor Ciphergen Express [46]. PPC [108] and Mean
Spectrum [82] also do well.
One counter-intuitive observation apparent in Table 6 is that for a fixed prevalence
range, mean sensitivity decreases with increasing abundance. The explanation for this is as
follows, and is addressed primarily in Figure 7. The simulation parameters, estimated from
real SELDI data, specify a negative correlation between abundance (mean log intensity of
peak height) and the log of mass of the protein in the simulation. In other words, high
abundance proteins occur at the lower end of m/z values in the simulations, where peak
density is the dominating factor that complicates peak finding, as discussed earlier. One of
the purported benefits of SELDI is its ability to observe hundreds of proteins simultaneously
in a complex medium such as blood serum. Our results indicate that this may not be so
advantageous, since more crowded peaks are difficult to resolve, even with the best programs
(Figure 7 bottom). The fact that peak density can be such a significant factor in peak finding
is motivation for higher resolution instruments and improved sample complexity reduction
methods.
2.5 Concluding Remarks
We now consider the entirety of our results and analysis. While the performance of all
algorithms is generally poorer than was expected, with roughly half of the 150 protein m/z
values being successfully recovered by the best algorithms, there is considerable room for
optimism and improvement.
Both by quantitative (e.g. MEANTPR as a function of mass, prevalence, and abun-
dance) and qualitative (e.g. usability and intuitiveness) measures, Ciphergen Express [46],
MassSpecWavelet [35] and Mean Spectrum [82] have a performance edge over the other
approaches. That is, they identify a peak within 0.3 percent of it’s true mass in a given
spectrum more often and more parsimoniously (i.e. in a simpler way) than the other algo-
rithms. The fact that Ciphergen Express performed well in our analysis should be welcome
news to the SELDI community, as this is the most commonly used program by researchers
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processing their data.
The best program we tested in terms of user friendliness was Ciphergen Express [46].
While it’s performance is among the top programs used in this study, we still recommend
analyzing one’s data with MassSpecWavelet [35] and Mean Spectrum [82] as well. Therefore,
we strongly recommend that biologists make the effort to explore their data using these
programs. We encourage biologists with little or no programming experience to collaborate
with statisticians, engineers, and computer scientists, as we have found such collaborations
to provide a true synergy. An excellent overview of the sources of variation in SELDI data
and what can be done to mitigate these effects is given in [96,119].
There is considerable opportunity for contributions in the area of signal processing
for MALDI/SELDI protein profiling experiments from statisticians, physicists, mathemati-
cians, engineers, and computer scientists.
We strongly believe that computational scientists have the same responsibility as lab-
oratory scientists to ensure their results are reproducible by the broader community. We
hold the ideas for reproducible computational research suggested by the Claerbout lab at
Stanford University as an ideal that the bioinformatics/proteomics community should strive
for [99] 1. Several of the software packages used in this study did not work when they were
first downloaded; all of them required various amounts of tweaking to get them going.
These hurdles could block a laboratory from using a technically superior package and pos-
sibly making a biomarker discovery. Therefore we strongly recommend that developers test
their software on other platforms before making them available to the community, and that
they support the software once it is made available.
Furthermore, we strongly encourage authors to make code available for download that
can easily be run to regenerate as many of the major results presented as figures and tables
in their paper as is feasibly possible. While this requires a small amount of extra effort, it
serves the community as a whole by speeding up the rate at which discoveries can be made
and confirmed. Towards this end, we have made available as supplementary information
approximately two gigabytes of Matlab code, perl scripts, and data that can be used to
1http://sepwww.stanford.edu/research/redoc/
33
generate the figures and tables used in this publication by running a few simple commands.
This is available via FTP from the authors by request.
There are several areas that stand out as needing immediate progress. First, we must
find ways to improve performance of the signal processing steps at low m/z values. There
are many important proteins with mass under 7 kDa that scientists will not want to miss.
Most signal processing suites explored in this paper took a top-down approach to design.
We believe that top-down approaches in this area have reached their potential. For progress
to continue in this area, researchers must come up with good models of the data derived
from a minimal number of sound assumptions. Malyarenko et al. has made some initial
progress in this way by using a charge accumulation model for the baseline drift observed
in MALDI/SELDI signals [72]. We recommend that more algorithms in the future make
use of physical models of the data first.
Looking farther down the road, high throughput, low resolution MALDI/SELDI protein
profiling will certainly benefit from a higher level of automation of the signal processing
steps. The trend in public health related studies is for the amount of patients/data generated
to be ever increasing. With protein profiling studies feasibly having thousands of patients
in case and control groups, it will become impractical to manually tweak parameters to











































































































































































































































































































































































































































































































































































































Table 6: Top two performers for different combinations of prevalence and abundance.
Performance is measured using mean sensitivity (MEANTPR).
Prevalence Abundance (a, mean log intensity)
p < 9.07 9.07− 9.72 > 9.72
0.00− 0.28 MassSpecWavelet 51.8% MassSpecWavelet 48.2% MassSpecWavelet 45.0%
PPC 47.7% PPC 43.1% PPC 41.3
0.28− 0.80 MassSpecWavelet 57.3% MassSpecWavelet 52.5% Ciphergen 50.6%
PPC 53.3% Ciphergen 50.0% MassSpecWavelet 48.2%
0.80− 1.0 MassSpecWavelet 58.7% MassSpecWavelet 53.4% Ciphergen 52.2%
Ciphergen 53.5% Ciphergen 53.0% Mean Spectrum 49.0%
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CHAPTER III
QUADRATIC VARIANCE MODELS FOR ADAPTIVELY
PREPROCESSING SELDI-TOF MASS SPECTROMETRY DATA
3.1 Abstract
Background: Surface enhanced laser desorption/ionization time-of-flight mass spectrom-
etry (SELDI) is a proteomics tool for biomarker discovery and other high throughput ap-
plications. Previous studies have identified various areas for improvement in preprocessing
algorithms used for protein peak detection. Bottom-up approaches to preprocessing that
emphasize modeling SELDI data acquisition are promising avenues of research to find the
needed improvements in reproducibility.
Results: We studied the properties of the SELDI detector intensity response to matrix
only runs. The intensity fluctuations and noise observed can be characterized by a natu-
ral exponential family with quadratic variance function (NEF-QVF) class of distributions.
These include as special cases many common distributions arising in practice (e.g.- nor-
mal, Poisson). Taking this model into account, we present a modified Antoniadis-Sapatinas
wavelet denoising algorithm as the core of our preprocessing program, implemented in
MATLAB. The proposed preprocessing approach shows superior peak detection sensitivity
compared to MassSpecWavelet for false discovery rate (FDR) values less than 25%.
Conclusions: The NEF-QVF detector model requires that certain parameters be mea-
sured from matrix only spectra, leaving implications for new experiment design at the
trade-off of slightly increased cost. These additional measurements allow our preprocessing
program to adapt to changing noise characteristics arising from intralaboratory and across-
laboratory factors. With further development, this approach may lead to improved peak




Mass spectrometry is a promising technology for biomarker discovery [59]. There are
a wide variety of mass spectrometers from which one could choose from during the de-
sign of a biomarker discovery experiment, reviewed in [32]. Matrix assisted laser desorp-
tion/ionization time-of-flight mass spectrometry (MALDI-TOF MS, or just MALDI) can
ionize whole proteins intact over a wide range of protein mass values, making it suitable
for biomarker discovery in complex media such as blood serum, where both protein concen-
trations and masses vary greatly [22]. Surface-enhanced laser desorption/ionization time-
of-flight mass spectrometry (SELDI-TOF MS, or just SELDI) [58] is a variant of MALDI
that adds an on-chip chromatographic separation step at the front end of the analysis
pipeline. This, combined with robot-automated sample preparation, enables SELDI to be
high-throughput, an attractive feature for many laboratories. For a recent review of the
application of SELDI in the context of biomarker discovery, see [10].
The typical SELDI work flow involves the collection of samples (e.g.- blood serum)
from patients, application of the samples to SELDI ProteinChips R© selected for desired
physicochemical properties, and analysis in the SELDI mass spectrometer. The raw data
must be preprocessed to detect relevant peaks which correspond to proteins in the sample.
Typical signal preprocessing steps performed are spectral alignment, denoising/smoothing,
peak detection, peak matching, normalization, and quantification (see Figure 1 of [39]).
The preprocessing of the raw SELDI spectra is typically accomplished using one of several
available software packages (reviewed in [24, 39, 117]). Artifacts due to insufficient pre-
processing of the data have, in the worst case, led to erroneous biological conclusions in
early SELDI studies [5,28,103]. This fact inspired several important comparison studies of
SELDI preprocessing algorithms [24, 39, 80, 117]. We now briefly summarize a few of the
major contributions. For a more detailed overview, see the introduction of [39].
Coombes et al introduced the use of wavelets for denoising SELDI spectra [21], pro-
viding a more adaptive approach to denoise compared to moving average filters (e.g., as
in [46]). Meanwhile, Morris et al introduced the notion of a mean spectrum, which rep-
resents average protein activity of a group of spectra. Under non-restrictive assumptions,
38
the mean spectrum has less noise and allows one to circumvent complicated peak match-
ing algorithms that consolidate peak predictions among individual spectra into a consensus
prediction. Malyarenko et al introduced a novel baseline removal algorithm based on a
proposed charge accumulation model of the saturation phenomenon of the detector [72].
This was one of the first algorithms that was designed from the “bottom-up”, starting with
physical considerations of SELDI. Later, deconvolution filters were shown to be a possible
approach for improving mass resolution of SELDI [48,73,74].
Sköld et al analyzed single-shot spectra [102], the basic components of a final SELDI
spectrum obtained by summing the results of many laser shots. They suggested that the
observed counts in the single shot spectra may be proportional to a Poisson random variable,
proposing a heteroscedastic model for the data. Meuleman et al also make use of single-
shot spectra (sub-spectra) to derive a preprocessing algorithm based on analyzing these
components separately [79].
In an attempt to improve on the bottom-up approach to preprocessing, we analyze the
statistics of the SELDI signal over a wide range of intensity values. Based on data presented
herein, we propose a natural exponential family model with quadratic variance function for
the statistics of the detector response for SELDI experiments. We believe this model is a
plausible explanation for acquisition of single-shot spectra, summing of single-shot spectra
into a final spectrum, and extracting protein estimates from a mean spectrum under a unified
framework. Under this framework, we introduce a new preprocessing approach, adaptive to
changing noise characteristics per spectrum and per experiment, and show favorable peak
prediction performance.
3.3 Results
3.3.1 Buffer-only intensity measurements
Electronic measurements exhibit natural random fluctuations [111]. In many cases, these
fluctuations are independent of the signal and are modeled as additive white Gaussian noise.
In order to understand the nature of the noise fluctuations inherent to SELDI, we study the
response of the detector under controlled experiments applying different buffers instead of
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protein samples under varying laser intensities (as in [96]).This eliminates the complexity
introduced by adding serum to the chips while facilitating measurements of ion counts over
a wide range of intensity values. In principle, this gives us a set of n repeated experiments
from which we can study the statistics of the detector response compounded with noise
and interference inherent to SELDI. In this fashion, we have generated two separate buffer
+ matrix datasets, denoted BUFFER1 and BUFFER2, which represent data generated on
the same SELDI PBS IIc machine by different scientists and different machine parameters.
BUFFER1/BUFFER2 contain 183/114 spectra, respectively.
We visualize all of the spectra in BUFFER1 and BUFFER2 in Figure 8. In particular, we
are interested in analyzing the region between 3 and 30 kDa, since this is the mass focusing
region in our experiments. In this region, the observations across spectra for a fixed time
(mass) point represent approximately independent, identically-distributed measurements in
BUFFER1 or BUFFER2, respectively. Figure 8 shows the median, 75% quantile, and 25%
quantile of BUFFER1 and BUFFER2. The median spectrum shows the form of an ordinary
measurement, with any measurement between the 75% and 25% spectrum lines considered
typical as well.
Figure 8 shows us the behavior of the typical buffer + baseline signal component seen
in all SELDI raw spectra. Indeed, we see that changing different machine settings leads
to different response properties. For BUFFER2, the median spectral response is large in
the range shown, and the distribution of responses is symmetric about the median, whereas
the distribution of detector response values for BUFFER1 are heavily skewed, and thus
certainly not normally distributed.
We study the detector response (intensity output) for SELDI under varying input condi-
tions, creating a detector response curve as follows. For each fixed time (mass) point across
spectra from BUFFER1 in the mass focused region [3kDa, 30kDa], we estimate the mean
intensity observed and the corresponding variance, with the same repeated for BUFFER2.
These are displayed as a scatter plot in Figure 9 along with the best fit quadratic curve.
Observing Figure 9 we see






















Figure 8: Quantile spectrum visualizations for all 183/114 spectra from
BUFFER1/BUFFER2 datasets respectively. The middle, upper, and lower spectra
are the 50% (median), 75%, and 25% quantile spectra respectively, calculated pointwise
for each mass point. The results show that different machine settings give rise to different
statistical behavior of the intensity values registered at the detector. Preprocessing
techniques should be able to adapt to this varying behavior.
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Figure 9: SELDI detector response curves. For repeated experiments under homogeneous
machine settings, the variance in intensities observed is shown to be quadratic in the mean
intensity observed. Thus, peaks occurring in areas of the spectrum affected near the baseline
will be more noisy and more difficult to detect. Most algorithms for preprocessing SELDI
data assume constant variance, independent of signal intensity. The detector response
curve is shown to be dependent on machine settings, as it is different for BUFFER1 and
BUFFER2.
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2. The variance of the detector response is a quadratic function of the mean, to a very
good approximation
3. The detector response curves for BUFFER1 and BUFFER2 are quite different, and
thus are dependent on the machine settings.
The detector response statistics thus exhibit a quadratic variance function. Briefly, a ran-
dom variable X is said to have a quadratic variance function (QVF) if
V (µ) = v0 + v1µ + v2µ2, (11)
with µ being the mean of X, V (µ) the variance, and v0, v1, v2 constants, some of which may
be zero.
From these observations, summarized in Figures 8 and 9, it seems unlikely that an
algorithm optimized for BUFFER1 would work well on BUFFER2 and vice versa. Further,
neither a homoscedastic approach (e.g. - standard wavelet shrinkage [33]) or a simple
heteroscedastic approach (e.g. - Poisson regression formulation [34]) to preprocessing the
data is likely to be sufficient.
3.3.2 Data for evaluating preprocessing algorithms
We have generated two new datasets for evaluating preprocessing algorithms in order to
improve upon purely simulation-based datasets used in previous comparison studies [24,39].
A good comparison dataset should have the following properties (discussed previously in
[39]):
1. Exact protein content is known (and thus expectation of where “true” peaks will
appear)
2. Analyzed sample is complex containing many proteins/peaks
3. Noise and baseline characteristics should be as close to those of real SELDI data as
possible.
If one uses simulated data [24,39,82], complete control can be attained over requirements 1)
and 2) at the expense of having noise/baseline characteristics that are overly ideal. If one
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uses purely real data, the noise, baseline, and artifacts that arise in actual experiments are
present. However, this usually accompanies the trade-off of either not knowing the exact
protein content (e.g.- complex serum data) or an overly simplified scenario (e.g. - spike-in
data).
We combine the advantages of purely simulated and real data by introducing the notion
of a hybrid spectrum. To generate a hybrid spectrum, we use an implementation of the
SimSpec 2.1 SELDI simulator [18, 82]1 to generate a “clean” SELDI spectrum, shown at
the top of Figure 10. This gives an accurate peak shape characteristic as would be seen
in low resolution SELDI/MALDI for given mass and ion abundance values, without any
electronic noise or baseline present. We then select one of our buffer + matrix spectra
(from either BUFFER1 or BUFFER2) and add the two together to produce the hybrid
spectrum shown at the bottom of Figure 10. Thus, in a hybrid spectrum we know the exact
virtual protein content specified to the simulator a priori while maintaining exactly the
same noise, baseline, and other artifacts one encounters with real SELDI data.
Further details on the hybrid spectra can be found in the Methods section and in ad-
ditional file 1: supplement.pdf. The collection of hybrid spectra under different operating
conditions results in test sets, denoted HYBRID1 and HYBRID2, with each test set contain-
ing thirty datasets of fifty hybrid spectra each. The mean performance of a preprocessing
algorithm on HYBRID1 and HYBRID2 can be interpreted as the expected performance of
the preprocessing approach in each separate operating condition in a repeated experiment
or sampling from a homogeneous population (e.g. - cancer group or control group).
3.3.3 New preprocessing algorithms for SELDI
We have developed a set of MATLAB R© scripts for preprocessing SELDI spectra named
LibSELDI. For information on how to obtain LibSELDI and the associated scripts used to
produce the figures in this paper, see additional file 1: supplement.pdf. We compare our
preprocessing package to the MassSpecWavelet package from the Bioconductor project [35].



















Figure 10: Construction of hybrid spectrum for testing preprocessing algorithms. (top)
Clean, pure protein component spectrum with no noise and no baseline simulated using
SimSpec 2.1 MALDI/SELDI simulation engine. Arrows over peaks show the m/z values
of the virtual proteins. (middle) Buffer+matrix spectrum generated in a SELDI PBS IIc,
representing noise, baseline, and artifacts that are typically seen. (bottom) Final hybrid
spectrum, consisting of the sum of simulated and real components. Hybrid spectra have the
advantage of having diverse signal components (150 virtual proteins) with exact knowledge
of the virtual proteins while retaining the true noise and baseline characteristics from real
SELDI data.
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in recent comparison studies [24, 39], and has been downloaded > 6000 times in the past
two years as of March 20102. Both packages have the advantage of having only one main
user-adjusted parameter.
In order to compare the performance of each preprocessing program, we generate oper-
ating characteristic curves (OC curves) [39,79], one for each of the 30 datasets of HYBRID1
and HYBRID2, by varying the Peak Area threshold (LibSELDI) and signal-to-noise ratio
threshold (Snr.Th in MassSpecWavelet) parameters in the programs. Code snippets show-
ing how MassSpecWavelet was tested can be found in additional file 1: supplement.pdf. This
allows us to understand the trade-offs between false discovery rate (FDR) and sensitivity
(TPR) achieved by each algorithm. The results for both the HYBRID1 and HYBRID2 col-
lections are shown in Figure 11, where we have plotted the fdr-axis in log scale to emphasize
the low FDR region which is usually of most interest in biomarker discovery applications.
Note that, since both HYBRID1 and HYBRID2 are collections of datasets representing re-
peated trials (or equivalently a homogeneous population), the OC curves we show in Figure
11 are the mean OC curves across the 30 datasets for each.
The results show that LibSELDI tends to have a considerable advantage in the low
FDR region, while MassSpecWavelet tends to have higher sensitivity for FDR > 25%. One
way to summarize the performance of the algorithms is using the area under the OC curve
for the FDR region of interest. We compute two area under the curve values, PAUC [39]
(calculated for FDR ∈ [0, 50%]), and PAUC25 (calculated for FDR ∈ [0, 25%]). The
results are shown in Table 7, where we have normalized each score separately so that a
perfect PAUC25 (likewise, PAUC50) score is 100.
In Figure 12, we show the specific operating characteristics for LibSELDI and MassSpecWavelet
for Dataset 2 of HYBRID1. While both algorithms perform well, LibSELDI resolves more
than 90 proteins correctly before making a mistake. Since operating characteristics show
false discovery rate along the x-axis rather than false positive rate (as in the traditional
ROC curves), they tend to penalize more when false predictions are made with very few











































Figure 11: Trade off between sensitivity and false discovery rate for LibSELDI and
MassSpecWavelet. Average loess-smoothed operating characteristics show the trade-offs
between sensitivity (TPR) and false discovery rate (FDR) for HYBRID1 and HYBRID2.
The mean loess-smoothed curve is indicated by the solid line, while the upper and lower
dashed lines indicate the 75% and 25% quartile curves. The FDR axis is shown in log-scale
to emphasize lower FDR values. LibSELDI demonstrates superior sensitivity compared to
MassSpecWavelet on both datasets for FDR values less than about 25%. MassSpecWavelet
has the advantage for FDR values greater than 25%.
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Table 7: Area under the operating characteristic comparison. Area under the operating
characteristic curve in a range of false discovery rate values of interest is a useful way to
compare peak prediction performance. We show two partial area under the curve metrics,
calculated in the range FDR ∈ [0, 50%] (PAUC) and FDR ∈ [0, 25%] (PAUC25). PAUC is
more of overall measure of peak prediction potential, while PAUC25 focuses on measuring
performance at low FDR. The number shown is the average (standard error) calculated











correct but its second prediction wrong, leading to the point at FDR=50%, TPR=7%.
Thus, operating characteristics with false discovery rate along the x-axis enforce the prin-
ciple of conservative decision making, rewarding approaches that are successful with their
initial large threshold (conservative) predictions and penalizing those that make mistakes
early.
At FDR values greater than 30%, MassSpecWavelet outperforms LibSELDI. However,
this is at the expense of generally more promiscuous predictions, since MassSpecWavelet
generates 586 potential protein predictions compared to 250 for LibSELDI.
3.4 Discussion
We posit that the detector response is a member of the Natural Exponential Family with
Quadratic Variance Function (NEF-QVF), which is a proper subset of the exponential
family of distributions [81]. Figures 8 and 9 show that assuming the detector response
takes the form of a specific distribution is impractical, but that the detector response V (µ)
has a QVF. The NEF-QVF family of distributions occur often in practice and have the
following useful properties, characterized by Morris [81]:
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Figure 12: Example operating characteristic. Operating points shown summarize the per-
formance of LibSELDI and MassSpecWavelet on Dataset 2 of HYBRID1 for many different
parameter choices. Each blue diamond is the (FDR, TPR) observed for a single choice
of Peak Area threshold for LibSELDI, while each red plus symbol shows the result of a
single Snr.Th parameter choice for MassSpecWavelet. For this particular example, Lib-
SELDI finds more than 90 true proteins before making a mistake. At high FDR conditions,
MassSpecWavelet resolves close to 90% of proteins compared to about 85% for LibSELDI.
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1. If a random variable X ∈ NEF-QVF, it is completely specified by its variance function
V (µ)
2. If X ∈ NEF-QVF, a, b constants then aX + b is also NEF-QVF
3. Additivity: If X1, X2 ∈ NEF-QVF, then X1 + X2 is NEF-QVF
4. Linear combinations of normal, Poisson, gamma, binomial, negative binomial, and
generalized hyperbolic secant distributed random variables generate all possible dis-
tributions in the NEF-QVF family.
There are some physical reasons as to why the NEF-QVF assumption could be reasonable
as well. Some plausible justifications for the first two terms in Eq. (11) are:
1. Constant Term: This is possibly due to thermal noise (additive Gaussian noise)
which is common to all electronic measurement devices [111]
2. Linear Term: The ability to detect an ion in a multiple stage electron multiplier,
a common type of detector in MALDI-like instruments, is described by compound
Poisson statistics [31].
The existence of a plausible physical explanation for the quadratic variance term remains
an open question. However its effect is measured in both BUFFER1 and BUFFER2 and
cannot be neglected. While the QVF model explains the data well in the mass focused region
between 3 and 30 kDa, it is likely to break down at lower masses around 2-2.5 kDA where
the baseline reaches a maximum. In this region the detector often saturates, introducing a
non-linearity into the data that we have not accounted for.
The success of our univariate model for SELDI may indicate that we have selected the
most important feature to consider in the preprocessing of the data: namely, the fluctuations
in the response of the ion detector subject to different inputs. The analysis of expression
values of preprocessed data, on the other hand, requires multivariate methods as there are
significant statistical dependencies between the peak heights corresponding to proteins that
may be interacting. While these correlations are important in the analysis performed after
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the data is preprocessed, our results indicated it may be safe to ignore them during the
preprocessing.
It is entirely possible that the quadratic variance model could be applicable to other
similar technologies such as MALDI and newer SELDI mass spectrometers. This, however,
has not been confirmed.
Having buffer only spectra allows one to estimate the parameters of the detector re-
sponse curve. Knowledge of the detector response curve enables us to apply the modified
Antoniadis-Sapatinas denoising scheme described in the methods. Using this approach in
our LibSELDI package yields excellent peak detection performance. We have proved this
concept on HYBRID1 and HYBRID2 by estimating the QVF parameters of (11) using the
buffer-only spectra that were randomly selected from BUFFER1 and BUFFER2 respec-
tively. This implies that spots on SELDI chips should be reserved for buffer-only spectra.
Thus, the trade-off for using our approach is increased cost in terms of the number of chips
one must use. The modified Antoniadis-Sapatinas denoising is computationally intensive as
well, taking approximately seven minutes per spectrum on a high-end workstation.
We argue that some of the cost is recovered by the potential for adaptive and accurate
preprocessing, but not all. It may be possible to use QC and/or calibration samples to
estimate the QVF as well rather than buffer-only spots. However, this would add in some
additional variation due to the nature of the medium (serum, plasma, etc).
While LibSELDI outperforms MassSpecWavelet on the HYBRID1 and HYBRID2 test
sets, the applicability of this comparison and of these results to purely real data remains
an open question. There is some basic biological variability modeled in our test sets (see
description in Supplement of [39]). However, data from complex biological samples such
as serum or plasma likely contains more biological variation and artifacts than we have
modeled in HYBRID1 and HYBRID2. The investigation of how biological variation affects
the model in QC samples is a work in progress.
In addition to achieving a better mean OC curve at lower FDR values, LibSELDI con-
sistently predicts fewer peaks than MassSpecWavelet, leading to protein predictions closer
to the true number of proteins in the data, as shown in Figure 13. This is further evidence
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Figure 13: Efficiency of peak/protein predictions. We show boxplots summarize the number
of peaks predicted for each program in the mean spectrum of each dataset from HYBRID1
and HYBRID2 before thresholding. LibSELDI consistently predicts around 250 peaks,
while MassSpecWavelet predicts more than 600 peaks consistently. MassSpecWavelet’s
more promiscuous predictions lead to high sensitivity at the expensive of higher false dis-
covery rate performance. LibSELDI’s peak predictions are reproducibly closer to the true
number of virtual proteins, 150 of them, present in each dataset.
that the adaptive modified Antoniadis-Sapatinas denoising approach using the NEF-QVF
model for the detector response is smoothing the spectra by close to the right amount.
3.5 Conclusions
We have shown that the variance of the intensity of a SELDI spectrum is quadratic in
the mean signal strength. We further make the flexible assumption that the underlying
distribution of the intensities is from a natural exponential family. From this point of view,
we use a modified Antoniadis-Sapatinas wavelet shrinkage approach for denoising SELDI
spectra. With this method at the core of our LibSELDI program for preprocessing SELDI
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data, we demonstrate excellent sensitivity at low false discovery rates. For applications that
can tolerate higher false discovery rates, the MassSpecWavelet algorithm performs better
in this region.
Our work has implications in the design of SELDI experiments. Namely, the modified
Antoniadis-Sapatinas denoising technique performs well but requires an estimate of the
quadratic variance function (QVF) describing the SELDI detector. This, in turn, is affected
by machine settings. We have used buffer-only spectra to estimate the QVF. Thus, buffer-
only spots could be interlaced on chips. We are investigating less expensive ways to estimate
the QVF in future work.
3.6 Methods
3.6.1 Protocol for generating buffer-only spectra
Buffer-only spectra were generated by interspersing buffer only samples with protein samples
from subjects (e.g. serum samples) and with pooled subject samples (for quality control)
on the same chip. The buffer-only samples were spotted with wash buffer that was either
PBS (phosphate buffered saline with various concentrations of phosphate and NaCl) based
or acetonitrile + TFA (triflouroacetic acid) based, as manufacturer recommended per chip
type. These buffer only samples were processed with the same washing steps as the subject
samples, as described in [96], and then SPA matrix was applied to all spots.
The samples were analyzed with the Protein Biological System II-cTM SELDI mass
spectrometer (Bio-Rad Laboratories, Inc., Hercules, CA). The machine settings (e.g. laser
intensity, detector sensitivity) and precise washing steps varied from buffer only spot to
buffer only spot, and were generally different between BUFFER1 and BUFFER2. Note
especially that laser intensities were generally higher for BUFFER2 than for BUFFER1. A
detailed list of machine settings is given in the supplement.
3.6.2 Hybrid data
Calculating performance statistics for comparison of MassSpecWavelet and LibSELDI re-
quires a large number of spectra emulating an experiment that was repeated many times. To
generate the HYBRID1 dataset, we combine each clean spectrum with one buffer+matrix
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spectrum from BUFFER1, and similarly we form HYBRID2 from BUFFER2 by combining
those spectra with the same clean spectra.
A basic model of repetitive experiments for SELDI is available with SimSpec 2.1 that
takes into account fluctuations in protein concentrations, m/z values, and prevalence in the
data. Using the SimSpec 2.1 model developed at the MD Anderson Cancer Center [18,82],
we generate 30 datasets containing 50 clean (noise and matrix-free) spectra each. Each
dataset consists of 150 virtual proteins and each spectrum within the given dataset con-
tains a proper subset of these proteins with fluctuating parameters according to the model
described in [82] and its supplement. The goal for the preprocessing programs in our perfor-
mance evaluation is to reconstruct the master list of 150 virtual proteins characterizing the
dataset. Repeated across all 30 datasets, we can calculate useful performance statistics. The
properties of the 150 virtual proteins themselves are drawn from a prior distribution that
was estimated from real data. See [82], or alternatively, the description in the supplement
of [39].
We use sampling to overcome the limitation of having much fewer spectra in BUFFER1
and BUFFER2 than we have clean spectra in preparation for testing the algorithms. In
principle the best way to construct the hybrid test sets would be to have one unique spec-
trum in BUFFER1 (likewise BUFFER2) for each spectrum in our clean protein-only set.
However, this would require 1500 buffer+matrix runs to be performed for both BUFFER1
and BUFFER2, an impractical amount of blank chips to run. Sampling from BUFFER1
(BUFFER2) provides a cost effective way to introduce variation in the noise/matrix char-
acteristics between the datasets in HYBRID1 (HYBRID2).
3.6.3 Preprocessing the spectra
First we consider a model for a single SELDI spectrum, X(t). We observe X(t), a random
process, on a discrete time grid t1, . . . , tm, where X(t) represents the intensity of the raw
SELDI spectrum observed at time (equivalently mass) point t. For all t, we assume that
X(t) is distributed according to a natural exponential family (NEF) with quadratic variance
function (QVF) equal to V (µ(t)) as in Eq. (11). The variance function V (µ) completely
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characterizes the NEF-QVF family. The goal of preprocessing in SELDI is to estimate µ(t),
the expectation of X(t), which is the signal corresponding to ions that hit the detector.
With a good estimate of µ(t), extracting peaks and estimating protein m/z values in a
dataset is relatively straightforward.
As a side note we point out that a SELDI spectrum is actually a sum of single shot
spectra. However, the additivity property of the NEF-QVF family guarantees the sum is
NEF-QVF provided that the single-shot spectra are NEF-QVF, agreeing with our detector
response model and experimental observations.
3.6.3.1 Multiple spectra considerations
Rather than observe a single spectrum, the typical biomarker discovery approach is to
generate at least one spectrum for each of n samples from an approximately homogeneous
population. For example, one homogeneous population may be a group of early stage
prostate cancer patients matched for age, race, etc. Assuming the samples are run on the
same SELDI machine with the same operating conditions, we have
X1(t), . . . , Xn(t) ∝ NEF-QVF (V (µ(t))) . (12)
Our assumption that all n patients have the same underlying µ(t) is equivalent to assuming
that the underlying biological condition being observed in each patient is approximately the
same. Thus, we wish to estimate the underlying commonality µ(t) related to the biology of
their condition expressed through the SELDI signal. We can mitigate some of the effects of







It is straightforward to show that





Thus, the mean spectrum concept is valuable under the assumptions of the NEF-QVF
model as well.
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3.6.3.2 Modified Antoniadis-Sapatinas denoising
We now discuss estimation of µ(t) from the mean spectrum (13). Since the Xk(t) are
sampled on a discrete time grid (and thus X•), we introduce vector notation
x• = [X•(t1), . . . , X•(tm)]′
µ = [µ(t1), . . . , µ(tm)]′.






Antoniadis and Sapatinas proposed a wavelet shrinkage scheme to solve for µ̂ in (16) in the
context of NEF-QVF regression [3]. We summarize their main results. For our denoising,
we use the orthogonal discrete wavelet transform with respect to the Symmlet 8 basis [25].
The transform can be represented by an m×m orthogonal matrix W,
w = Wx•. (17)
Let h be a length m vector with entries taking values between 0 and 1. Let H = diag(h)
be the m×m matrix defined by placing the entries of h along the main diagonal, all other
entries 0. The class of estimators for µ̂(x•) considered by [3] take the form
µ̂(x•) = W ′Hw
= W ′HWx•. (18)
This is the typical wavelet denoising scenario where each wavelet coefficient is left alone or
shrunk towards zero according to some criterion, and is completely defined by the vector
h. Antoniadis and Sapatinas showed that a good estimator for data from the NEF-QVF







, i = 1, . . . ,m
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z, z ≥ 0
0, z < 0.
56




(W · W )V (x•). (19)
Where V (x•) is the vector constructed by applying the QVF from (11) to each term of
x•. (W · W ) is the matrix whose i, j element is the square of the i, j element of W . The
parameters v0, v1, v2 in (11) are measured from the buffer-only spectra, as described in the
Results and Discussion section.




(W · W )V †(x•)
V †(x•(i)) = max {V (x•(i)), v0} .
Thus our modified Antoniadis and Sapatinas estimator h̃ uses σ̃2 in (18) rather than σ̂2.
The modification was introduced to account for cases when (19) may underestimate the








Then, our modified Antoniadis-Sapatinas estimate of µ is defined as
µ̃ = W ′H̃Wx•. (20)
3.6.3.3 Peak detection/baseline removal
We consolidate the two preprocessing steps of baseline removal and peak detection typically
performed separately into a single step as follows. We assume that the underlying µ(t)
shown in (14) is the superposition of protein ions, s(t), and energy-absorbing matrix ions,
b(t) striking the detector. It is well known that the distribution of the isotopes in our
analyte of interest gives rise to a roughly Gaussian peak shape. Thus, we propose




ajG3σj (tj , σj) (22)
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where, Gα(tj , σj) denotes a Gaussian kernel function centered at tj with standard deviation
σj and zero outside the interval [tj − α, tj + α].
Typically, s(t) is very sparse in the sense that it is mostly zero over the domain of the
observed signal. Therefore, the local minima of our estimated baseline + noise signal µ̃ are
points we may assume touch the baseline. From this point of view, once we have detected
all the local minima in µ̃, the baseline curve estimation problem reduces to an interpolation
problem amongst these points. We have found through experimentation that piecewise
cubic Hermite interpolating polynomials [45] are excellent interpolation functions.
The minima and maxima in µ̃ are found in one pass using the extrema function down-
loadable from MATLAB R© central file exchange. The maxima are the peaks in the mean
spectrum potentially indicating proteins represented in our sample population while the
minima correspond to samples from the baseline signal.
Each detected peak is quantified using peak area and a threshold is chosen based on the
peak area measurement to generate the final prediction set.
3.6.4 Operating characteristics
The peaks we detect in µ̃ represent the initial set from which we choose our final esti-
mates of proteins that are active in the population of interest. The choice of final estimate
is accomplished using a peak area threshold (LibSELDI) or signal-to-noise ratio measure-
ment (Snr.Th in MassSpecWavelet). From each prediction, we calculate the observed false









Where TP (the number of true positives) is the number of the 150 virtual protein m/z values
having at least one predicted m/z value within 0.3% relative error. The FP is defined as
the number of predicted m/z values not within 0.3% of any of the 150 virtual protein m/z
values for this dataset. Similarly, FN is the number of the 150 virtual protein values without
any predicted m/z value within 0.3% relative error.
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For each dataset, a curve is fit to the operating points. Each operating curve is averaged
to produce a mean operating characteristic, as shown in Figure 11. From this curve, the
calculation of the area-under-the curve is straightforward. For more details, see sections 2.2
and 2.2.1 of [39].
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CHAPTER IV
EXPLAINING REPRODUCIBILITY OF PEAKS IN SELDI MASS
SPECTROMETRY: THE QUADRATIC VARIANCE MODEL
4.1 Introduction
The reproducibility of peaks in surface-enhanced laser desorption/ionization time of flight
mass spectrometry (SELDI) has been problematic. In 2002, Petricoin developed an ap-
proach for the early detection of ovarian cancer based on SELDI [90]. Further scrutiny of
this study revealed artifacts in the data that biased the results given by Petricoin [5, 103].
This led to several important papers studying experimental pre-analytic and analytic fac-
tors affecting reproducibility [77, 78, 100, 109]. Recently, several studies have been per-
formed studying post-analytic factors of reproducibility, namely, the preprocessing of the
data [24, 39, 80, 117]. These studies indicate clearly that the choice of preprocessing algo-
rithms leads to significantly different results with respect to the quality of the peaks found
in the data. Continuing concerns about reproducibility are highlighted in the recent article
by Wei et al [118].
One factor contributing to our poor understanding of reproducibility for SELDI is the
lack of bottom-up models characterizing the measurement process. By default machine
settings, a SELDI spectrum is the result of pooling/summing numerous single-shot spectra.
Sköld et al studied the acquisition of single shot spectra and proposed a statistical framework
for pooling the single shot spectra [102]. They introduced an expectation-maximization
algorithm for combining the spectra that results in improved peak heights in the pooled
spectrum. Malyarenko et al introduced a charge-decay model for the baseline in a SELDI
spectrum and used time-series methods for the common preprocessing tasks. Recently,
Emanuele and Gurbaxani have proposed a quadratic variance model for the response of
the detector to buffer-only plus matrix sample runs, which leads to preprocessing methods
showing improved performance [40].
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Cervical mucous is an important biological medium to understand in order to increase
the chances of finding biomarkers for the early detection of cervical cancer. Recently there
have been efforts to characterize the cervical mucous proteome (e.g. [87]). In this paper, we
test the sufficiency of the quadratic variance model for explaining SELDI spectra generated
from pooled cervical mucous QC data and finding reproducible peaks.
4.2 Materials and Methods
4.2.1 Cervical Mucous and Patients
Cervical mucous samples were collected from women attending coloposcopy clinics as de-
scribed in [87].
4.2.2 SELDI mass spectrometry
Pooled cervical mucous was spotted on chips intermittently as part of a QC step in the
experiment design. Patient samples were also spotted on the same chips although we do
not use the patient cervical mucous samples in this study.
Mass spectrometry analysis was performed using the Protein Biology System IIc SELDI
mass spectrometer (Bio-Rad Laboratories, Hercules, CA). Mass focusing was optimized for
the 3 kDa to 30 kDa region. Data collection from start to finish took 2 weeks. We collected
the spectrum from pooled mucous QC samples for the low laser setting, CM10 array, for
analysis in this study. In total, there were 36 spectra. Five of the spectra had already been
through one freeze/thaw cycle before analysis. These spectra were removed leaving us with
a final dataset of 31 pooled-mucous QC spectra.
4.2.3 Quadratic variance model
We fit a quadratic model to the variance of the data by measuring the mean and variance
from hand selected regions of the QC spectra where peaks are visibly absent in all of the
spectra. The quadratic variance model implies that the mean µ and variance V (µ) have
the relationship
V (µ) = v0 + v1µ + v2µ2. (25)
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Emanuele and Gurbaxani have previously shown this is a good model for measurements
of the resulting spectra from buffer washed, matrix-only spectra containing no biological
signal or protein content [40]. In principle, the measurement of the data in between peaks
should be a sufficient approximation to this as long as we take it over a large enough mean
intensity range to enable good curve fitting.
The quadratic variance model can be used to make testable predictions about how peaks
should behave in the spectra of a SELDI experiment. One subtle aspect of Eq. (25) is that
it predicts what the CV of our measurements should be,








v0µ−2 + v1µ−1 + v2 (26)
≈ 100 ·
√
v2 (µ large). (27)
We summarize the deductions/predictions made by the quadratic variance model that will
be tested in this paper:
1. Peak heights across spectra corresponding to the same underlying biology should have
mean heights and variances consistent with the estimated quadratic variance function
of (25)
2. The measured CV values of peak heights should be consistent with (26)
3. For very large peaks, the CV of peak heights should be approximated by (27)
4. An algorithm that uses the quadratic variance nature of the measurements (LibSELDI
[40]) should find more reproducible peaks than Ciphergen Express [46].
4.2.4 Preprocessing with LibSELDI
The LibSELDI preprocessing package being developed in MATLAB R©(The Mathworks, Nat-
ick, MA) is the first to take into account a quadratic variance form of the measurement error.
The details of the algorithms used with LibSELDI have been described previously [40]. We
use this technique to process the data adhering to the following protocols:
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• A single quadratic variance function (QVF) is estimated representing all 31 QC spectra
• The QVF is estimated according to the procedure described in Sec. 4.2.3
• Preprocessing is performed on each spectrum individually rather than the mean spec-
trum as was done in [40].
4.2.5 Preprocessing with Ciphergen
Ciphergen Express is the most popular preprocessing suite for working with SELDI data.
The precise procedure used to preprocess the data and produce peak predictions with Ci-
phergen is described in [86].
4.2.6 Peak matching algorithm
We propose an algorithm for matching peaks with similar m/z values in different spectra
that are assumed to be from the same underlying protein. A useful formulation of this
problem is using graph theory, where peaks are represented by vertices and two vertices
have an edge between them if their m/z values are within a specified tolerance. A clique is
defined as a set of vertices for which all pairs of vertices contain an edge. In other words,
a set of peaks that are all sufficiently close to each other in m/z value to be considered
from the same underlying protein across QC spectra. From this point of view, we have
formulated the peak matching problem as a maximal clique finding problem. In the general
case, this problem is known to be NP-hard. However, we are able to exploit the special
structure of our data to devise a clique finding algorithm that is solved in polynomial time.
For details, the interested reader is referred to the code accompanying our manuscript.
4.3 Results
The quadratic variance function can be reliably estimated from the gaps of the spectra in
between the peaks. This is shown by the graph in Figure 14. This confirms that the area
interspersed between peaks in SELDI follow the quadratic variance model.
LibSELDI consistently finds more peaks that Ciphergen Express does. This is shown
in Figure 15. LibSELDI finds between 100 to 200 peaks per spectrum in the 3 to 30 kDa
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Figure 14: Variance of measurements are a quadratic function of the mean. The blue circles
indicate mean/variance points estimated from regions in between peaks in the spectra. The
solid magenta line is the best fit quadratic variance function, while the dotted magenta lines
indicate plus/minus one standard error.
range. This is a reasonable number to expect for such a range of mass values. Note that
the number of peaks predicted is always less than the peak capacity as defined by [18].
LibSELDI finds more than four times as many reproducible peaks as Ciphergen express.
This is illustrated in Figure 16. Most biologists are interested in the number of peaks found
with a prevalence greater than 80%. LibSELDI finds 84, while Ciphergen express only finds
18.
Mean peak heights and peak height variances are consistent with the quadratic variance
model in the majority of cases. We restrict our analysis to peaks appearing in at least 50%
of the spectra (guaranteeing at least n=16 for sample means and variances). We illustrate














Number of peaks predicted per spectrum
Figure 15: LibSELDI finds more peaks per spectrum than Ciphergen Express. Box-plots
are shown with the y-axis indicating number of peaks predicted in a QC spectrum. The
predictions corresponding to LibSELDI is indicated by a 1, while Ciphergen is demarcated
by a 2 on the x-axis.
few cases with peaks of very high mean intensity occurring in the spectra, the model does
not fit. This is shown in Figure 18.
The CV values of peak heights observed are consistent with the predictions of the
quadratic variance model in most cases. We illustrate this in Figure 19. Similar to what
we saw in Figure 18, the model breaks down for peaks at very high mean intensity, which
are a small minority of our observations. This breakdown at high intensities is shown in
Figure 20. Note, however, that the predictions are still bounded below the large µ CV
approximation predicted by the model in Eq. (27).
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Figure 16: LibSELDI finds more reproducible peaks than Ciphergen Express. LibSELDI
finds 84 peaks occurring in at least 80% of our QC spectra, while Ciphergen finds only 18
such peaks.
4.4 Discussion
The quadratic variance model of measurement for SELDI explains most of our observations
about the reproducibility of peaks in this study. Examining Figures 14, 17, 18, 19, and
20, a picture starts to emerge of a measurement model that is constant variance for mean
intensities below 3700, quadratic variance between 3700 and 12000, and possibly transition-
ing to constant variance for very high intensities above 12000. A large majority of the peak
heights from the pooled mucous QC samples were observed in the quadratic variance region.
More work is needed to understand the behavior at very high intensities. This model may
also be generalizable to MALDI since the technology is actually very similar SELDI.
The LibSELDI preprocessing approach, taking into account the quadratic variance of
66















Figure 17: Mean peak heights and peak height variances are consistent with the quadratic
variance model for most peaks. The blue points indicated the mean/variance pairs from
non-peak regions used to estimate the model. The red plus symbols corresponding to
peaks occurring in at least 80% of QC spectra, while the grean plus symbols indicate peaks
occurring in 50% - 80% of QC spectra. The dashed (dotted) magenta lines indicates one
(two) standard errors from the mean, respectively.
the data, demonstrates certain strengths. By measuring the characteristics of the noise
associated with a set of experimental conditions and machine settings, LibSELDI is able
to adapt to changing noise/background characteristics. The peak matching algorithm for-
mulated as a clique-finding algorithm performs favorably. The sensitivity demonstrated for
finding peaks occurring in more the 80% of the spectra is impressive– finding more than
four times as many as Ciphergen (84 peaks versus 18). Further, the protein estimates/peaks
found by the model had mean peak heights, variances, and CV’s that are consistent with
what would be predicted by the model. Thus the quadratic variance function estimation,
estimated rather simply, says something about how reproducible our peaks are going to be
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Figure 18: Mean peak heights and peak height variances for very large mean height val-
ues are not consistent with the quadratic variance model. The blue points indicated the
mean/variance pairs from non-peak regions used to estimate the model. The red plus sym-
bols corresponding to peaks occurring in at least 80% of QC spectra, while the green plus
symbols indicate peaks occurring in 50% - 80% of QC spectra. The dashed (dotted) magenta
lines indicates one (two) standard errors from the mean, respectively.
in advance of an experiment run.
The are limitations to the LibSELDI approach, however. The modified Antoniadis-
Sapatinas algorithm at the core of LibSELDI is computationally intensive– requiring ap-
proximately 7 minutes of processing time per spectrum on a Dell Precision 690 with 12
Gigabytes of RAM. The model is likely to break down at m/z close to around 2.5kDa where
the baseline saturates due to non-linearities introduced by the detector saturating. In this
region, Figure 17 implies that the algorithm may over-estimate the noise thus possibly
over-smoothing and missing a peak.
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Figure 19: Observed CV values of peaks are consistent with the quadratic variance model
in most cases. The blue points indicated the mean/CV pairs from non-peak regions used
to estimate the model. The red plus symbols corresponding to peaks occurring in at least
80% of QC spectra, while the grean plus symbols indicate peaks occurring in 50% - 80% of
QC spectra. The dashed (dotted) magenta lines indicates one (two) standard errors from
the mean, respectively.
Although LibSELDI demonstrated superior peak detection performance on our cervical
mucous QC data, Ciphergen Express still has certain strengths. First and foremost, it is
a mature software package easily usable by the community. In contrast, LibSELDI is still
in development and thus some MATLAB programming expertise is required to use this
package in addition to the availability of good computing resources. However, the main
drawback of Ciphergen in this paper is its lack of sensitivity as illustrated clearly in Figures
15 and 16.
The quadratic variance model has been demonstrated to explain the variation observed
in cervical mucous QC data, leading to more reproducible peak detection and predicting
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Figure 20: Observed peak height CV values for peaks at very high intensity are not con-
sistent with the quadratic variance model. The blue points indicate the mean/CV pairs
from non-peak regions used to estimate the model. The red plus symbols corresponding to
peaks occurring in at least 80% of QC spectra, while the grean plus symbols indicate peaks
occurring in 50% - 80% of QC spectra. The dashed (dotted) magenta line indicates one
(two) standard errors from the mean, respectively.





If there is a single item of knowledge that is to be remembered from this dissertation it is
this: the acquisition of SELDI mass spectrometry measurements follow the quadratic vari-
ance model. From this, almost everything else can be deduced including the preprocessing
techniques used and our expectations about the reproducibility of peaks in the data.
The full list of contributions of this work are:
• We produced one of the first large-scale comparisons of SELDI preprocessing algo-
rithms to date consisting of the comparison of 9 different approaches on a test set of
10,000 spectra. Several benchmarking metrics were used for this study taking into
consideration the needs of both computational scientists and laboratory scientists
(which are in fact often quite contradictory). These simulations consumed more than
a year of CPU time. This resulted in a publication in the journal Proteomics [39],
with a figure from our publication being chosen as one of the figures on the cover of
the issue.
• We proposed a natural exponential family with quadratic variance function model for
the acquisition of SELDI data based on an analysis of buffer/matrix only spectra. We
conjecture that this model captures the behavior of the detector.
• We introduced the modified Antoniadis-Sapatinas wavelet denoising algorithm that
takes into account the quadratic variance model to denoise each spectrum by the right
amount [40].
• We have developed a collection of preprocessing algorithms, including the modified
Antoniadis-Sapatinas algorithm, implemented in Matlab in a package we call Lib-
SELDI. We have contributed 30,000+ lines of code to LibSELDI (printed out, this
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would span 500+ pages). LibSELDI is licensed under v3 of the GNU public license and
is intended to form the core of a free and open sourced replacement for the expensive
Ciphergen Express software sold with SELDI.
• We have adhered to the concept of reproducible computational research in the sense
that all of our publications are released with the code and data necessary to reproduce
our figures by simply running a script named “pulishedfigures.m”.
• Lastly, we have shown that the quadratic variance model, based on measuring blank
regions of a spectrum, explains the observed peak behavior of pooled cervical mucus
QC spectra from data being used in an early cancer detection project here at the
CDC. For these spectra, LibSELDI finds 84 reproducible peaks in comparison to 18
for Ciphergen Express.
The notion of quadratic variance of the measurements is fundamental and has the potential
to impact numerous publications. In Figure 21, we show the trends in publications for
SELDI in the past 10 years. Nearly all of these papers preprocess SELDI mass spectrometry
data and thus may be impacted by our work, provided that further validation of the model
continues to vindicate its use.
5.2 Publications
The work related to this thesis has resulted in several publications, which are listed below.
5.2.1 Journals
[J1] V. A. Emanuele II and B. M. Gurbaxani, “Benchmarking Currently Available
SELDI-TOF MS Preprocessing Techniques,”Proteomics 2009 Apr; 9 (7), pp. 1754-62.
Figure from paper selected for cover of issue.
[J2] V. A. Emanuele II and B. M. Gurbaxani, “Quadratic variance models for adaptively
preprocessing SELDI-TOF mass spectrometry data” accepted subject to revisions in
BMC Bioinformatics
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Figure 21: Publication trends for SELDI for the past 10 years. This is a figure that was
generated from inspiration from the analogous figure in [118].
[J3] V. A. Emanuele II, G. Panicker, B. M. Gurbaxani, and E. R. Unger, “Explaining
reproducibility of peaks in SELDI mass spectrometry: the quadratic variance model”
in preparation with co-authors for Clinical Chemistry. Expected submission date:
September 2010.
5.2.2 Conferences
[C1] V. A. Emanuele II and B. M. Gurbaxani, “Modeling uncertainty in SELDI mass
spectrometry with applications to biomarker discovery in complex biological media”,
poster presented at the National Center for Enteric, Zoonotic, and Infectious Diseases
Science Summit, Centers for Disease Control and Prevention, Atlanta, GA, August
24, 2010.
[C2] G. Panicker, V. Emanuele II, B. Gurbaxani, D. Lee, and E. Unger., “Enroute to
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protein biomarker discovery for early-detection of cervical cancer,”, Poster presented
in CDC Celebrates 10 Years of Public Health Genomics: Translating Gene Discoveries
into Population Health Benefits, Atlanta, Ga, January 23, 2008.
[C3] V. A. Emanuele II and B. M. Gurbaxani, “Comprehensive Performance Analysis of
SELDI-TOF Mass Spectrometry Signal Processing Methods,” Poster in 2nd Annual
Computational and Systems Biology Symposium, University of Georgia, March 23rd,
2007.
[C4] V. A. Emanuele II and B. M. Gurbaxani, “SELDI-ToF based protein profiling
for early detection of cancer and biomarker discovery: an evaluation of currently
available signal processing platforms,” Poster in AACR Advances in Proteomics in
Cancer Research, Amelia Island, FL, February 27-March 2, 2007.
[C5] V. A. Emanuele II, V. Olman, B. Yan, Y. Xu, and G. T. Zhou, “An Approximate
Bayesian Detection Scheme with Applications to Tandem Mass Spectrometry Data
Analysis,” in Proceedings of the 12th Digital Signal Processing Workshop (DSP 2006),
pp. 550-560, Jackson Hole, WY, September 2006.
[C6] B. Yan, G. T. Zhou, P. Wang, Z. Liu, V. A. Emanuele II, V. Olman, and Y. Xu, “A
Point-Process Model for Rapid Identification of Post-Translational Modifications,” in
Proceedings of the Pacific Symposium on Biocomputing (PSB), pp. 327-338, Wailea,
Maui, Hawaii, January 3-7, 2006.
[C7] V.A. Emanuele II, T. T. Tran, and G. T. Zhou, “A Fourier Product Method for
Detecting Approximate Tandem Repeats in DNA,” in Proceedings of the IEEE Work-
shop on Statistical Signal Processing, Bordeaux, France, July 17-20, 2005.
[C8] T. T. Tran, V. A. Emanuele II, and G. T. Zhou, “Techniques for Detecting Approx-
imate Tandem Repeats in DNA,” in Proceedings of the IEEE International Conference
on Acoustics, Speech, and Signal Processing, Montreal, Canada, May 17-21, 2004
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APPENDIX A
ADDITIONAL COMMENTS AND NOTES SUPPLEMENTING THE
BENCHMARKING STUDY
We have approximately 2 GB of Matlab code, perl scripts, and data that we will make
available upon request via FTP. This code by itself could be used as a toolbox of sorts for
taking results, formatted properly, from a new program to be benchmarked and performing
the same analysis we have published. We include a few scripts that will regenerate all
the figures and tables presented in the published paper and supplementary information
herein. There is additional information included in this larger supplement, including tables
of parameter combinations used and the corresponding operating points observed, that may
be of interest to the community.
A.1 Choosing algorithms in the study
Our primary goal was to benchmark algorithms and techniques that are accessible to prac-
ticing scienctist. With this in mind, we decided that the SELDI preprocessing platforms
must satisfy the following criteria to be included in the study:
1. Availability: The software must be available. Available means that we must be able
to download the source code and install the package ourselves at no charge. This does
not include software that authors are not willing to share with us.
2. Output Format: The software must produce a list of m/z values detected as pro-
tein mass values detected in the group of spectra, along with corresponding intensity
estimates.
3. Usability: The software program must be usable by someone who is not an expert
in computer science and/or bioinformatics.
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A.2 Model for MALDI/SELDI Protein Profiling Data
We briefly describe the model used in the MS simulation engine, emphasizing the aspects of
the model that our critical for our work (see [18,82] and the accompanying supplementary
information for the original description given by Morris, Coombes, and colleagues).
A.2.1 Sample Collection
The MS simulation engine uses a simple model for sample collection that, in our opinion,
is an accurate reflection of the first order characteristics observed in our SELDI data. A
protein population in this model is completely characterized by modeling the distribution of
four quantities, p, log(x), a, s. The parameter p is the protein prevalence [18], which is the
probability that a protein occurs in a spectrum drawn from this population. This models
the common observation that peaks at a corresponding m/z often occur in some fraction of
the spectra in one’s data, but often do not occur in all spectra. This distribution of protein
prevalences in our population is modeled using the beta distribution [82].
The vector parameters θ = (log(x), a, s) are the logarithm of the protein mass, the
mean log-intensity value of the peaks in the spectra generated by the corresponding protein
(called abundance), and the standard deviation of the log-intensity of the peaks in the
spectra generated by the corresponding protein. Morris and colleagues have assessed that
a multivariate normal distribution is sufficient for accurately describing θ [82].
The parameters {p, θ} in this model and their corresponding distribution functions
represent a characterization of the behavior of all the proteins in this population as a whole.
For example, we could imagine different parameterizations {p, θ} for serum samples from
prostate cancer patients and healthy men. Thus we are positing that each time we ask 100
prostate cancer patients to come to the clinic, it amounts to observing a sampling from p
and θ for each of, say, 150 proteins. Thus, for this sample population of 100 prostate cancer
patients, we have values p1, . . . , p150,θ1, . . . ,θ150 for the proteins that could be observed
in this group. For each patient, we evaluate the possibility of each of these 150 proteins
being observed by sampling from a uniform random variable U on [0, 1], where the protein
is observed if uj < pj . For each protein that is observed in this spectrum, we next sample
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from the corresponding normal distribution with mean aj and standard deviation sj that
describes the behavior of the log-intensity, and map this value to an ion count (number of
proteins present at this corresponding mass for this patient) as is described in [82] and its
supplementary information. This model appears to capture the first order variations in data
collected from patients who represent the same population (e.g. prostate cancer patients),
sampled from different clinics.
A.2.2 Ionization/Desorption
The largest factor affecting variability in flight time for the same protein is arguably its
initial velocity upon ionization. Interestingly enough, the initial velocity off of the sample
plate is roughly independent of mass and is modeled with a normal distribution [64].
A second order effect is the variation of mass for a given protein due to the distribution
of isotopes of common elements such as carbon, nitrogen, and oxygen. This variation is
modeled in the simulation engine using a simple binomial model [18].
A.2.3 Analysis and Detection
Once the mass and initial velocity are sampled for all the particles corresponding to protein
A, the time of flight is calculated deterministically, assuming typical machine settings and
geometry for a low resolution MALDI [18]. When the virtual spectrum is generated, an
exponentially decaying baseline signal and white Gaussian noise process are added to the
spectrum to account for detector saturation and electronic noise, respectively. The i.i.d.
Guassian noise process is zero mean with a standard deviation of 66. For details of what
the parameter settings are for the simulated data, see [18,82] and the provided data.
A.3 Notes on how parameters were chosen for each algorithm
In selecting the parameter ranges to explore for each program, we adhered to a few basic
rules.
1. When code was available demonstrating how to use the programs, we attempted to
mimic the example in our implementation.
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2. If certain ranges of values were recommended in published literature or documentation
accompanying the programs, we followed these guidelines.
3. We explored as many parameter combinations as possible given the runtime and
efficiency of the algorithm.
The structre of some programs, such as MassSpecWavelet [35] and Mean Spectrum [82],
lent themselves to easy evaluation. For these programs, we could simply order all the protein
predictions by their SNR value and move the threshold from highest to lowest to generate
a huge number of operating points quickly. These sort of tricks have been discussed in [43].
Other programs, such as Bioconductor PROcess [49] and Genepattern, were extremely
computationally intensive and more challenging to evaluate. To evaluate these slower pro-
grams we used a small computing cluster containing 8 nodes.
Unfortunately, Ciphergen Express [46] has no scripting capability and the evaluation of
this program was laborious. In order to decide which parameter combinations to try for this
program, we selected five parameter combinations that gave us rougly 20, 50, 150, 300, and
600 protein predictions for Dataset 1. This way, although we generated only 5 operating
points, it was spread out over a range of operating capabilities.
The tables of parameter values and their corresponding operating points for each pro-
gram on each dataset is contained in the supplementary datasets available via FTP (see
README.txt for exact location).
A.4 Example Predictions
Finally, we present some example predictions of the top performing programs to facili-
tate a discussion of strengths and weaknesses of the algorithms. We focus our analysis
in this section on three preprocessing programs: Ciphergen Express, Mean Spectrum, and
MassSpecWavelet. Ciphergen Express and Mean Spectrum were the top two programs with
respect to the PAUC measure, while MassSpecWavelet was the top finisher with respect to
MEANTPR. If one were to consider the sum of the ranks of the programs with respect to
PAUC and MEANTPR as a measure of a program’s potential, these programs would be
the top three.
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Figure 22 shows example peak predictions for Dataset 10 of the simulated data. Each row
m/z (kDa)



























Figure 22: Example peak predictions of the top three programs on Dataset 10. Ciphergen
Express, MassSpecWavelet, and Mean Spectrum are shown in purple, light blue, and dark
blue, respectively. Note that all 100 spectra in Dataset 10 are displayed here as a heat map.
The red dots indicate location of the actual protein m/z value used in the simulation.
corresponds to a spectrum from the dataset, with the log-intensity of the spectrum displayed
as a grayscale heatmap. In the figure, white represents high intensities and black represents
zero intensity. The red circles on the x axes represent the m/z values of known virtual
proteins in the dataset, and the vertical lines represent protein predictions by the various
programs. Predictions made by Ciphergen Express, Mean Spectrum, and MassSpecWavelet
are shown in purple, dark blue, and light blue respectively.
Briefly observing all of the figures, we can make a couple general observations. First,
it is clear that Ciphergen Express seems to only predict the existence of a protein when
it is very sure. Unfortunately, the Ciphergen Express preprocessing algorithms are largely
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a “black box” of sorts. Thus, it is difficult to say why the program performed as it did
since the details of algorithms are not completely available. The conservative nature of the
Ciphergen Express program is evident in its top ranking with respect to the PAUC metric.
We regard this as a virtue.
On the other hand, Mean Spectrum and MassSpecWavelet do well at recovering the
protein m/z values from the data at the expense of a multiplicity of predictions. Indeed,
Figures 22a, 22b, and 22d illustrate that these programs tend to predict clusters of peaks
in the area of a true protein. This is perhaps a consequence of the way both programs
apply the wavelet transform. Since lower mass peaks tend to have higher intensities, the
corresponding wavelet coefficients for the wavelet bases at fine resolution turn out to be
large, thus making these two wavelet-based techniques more sensitive than expected to
narrow spurious noise peaks. One possible way to improve the wavelet based methods could
be to incorporate knowledge of the expected peak resolution for SELDI in an adaptive, m/z
dependent, wavelet coefficient thresholding.
We have provided matlab code used to generate the figures used in this publication and
additional information in the supplementary information.
A.5 Information about Matlab code, perl scripts, and data supplement
available via FTP
Note below is a reprint of the README.txt file included with the 2GB supplement.
----------------------------------------------------------
S.1 - How to reproduce the figures published in this paper
----------------------------------------------------------
Requires: Matlab v.7.3 (R2006b) or later and read/write access to the
MATLABROOT directory.
1) These directions assume you have followed the accompanying directions with
this zip file and successfuly unzipped this file in the ’work’ subdirectory
of the MATLABROOT folder. This then creates the EmanueleSuppl subdirectory
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in the work subdir.
2) Start matlab.
3) Set current working directory to the MATLABROOT/work/EmanueleSuppl dir (on
linux) or MATLABROOT\work\EmanueleSuppl on a Windows machine. This can be
done as follows.
Ex:
>> cd( fullfile( matlabroot, ’work’, ’EmanueleSuppl’ ) )
>>




publishedfigures.m: Note: Figure 1 was hand-made (nothing to simulate)
publishedfigures.m: Generating figure 2...
publishedfigures.m: Done!
(and so forth as the program continues to run)
5) Next, type ’publisheddatafast’ at the Matlab command prompt. This displays
the stats used to generate the tables from the publication.
6) Using a similar procedure, the supplementary info/figures can be generated
as well. See Table of Contents listing in the next section.
---------------------------------------
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S.2 - Table of Contents w/ descriptions
---------------------------------------
We briefly describe the organization of the supplementary info in our
paper. Note that we do not list every directory/subdirectory contained here but
only highlight what we believe to be the main ones of interest
***Scripts used to reproduce results***
publisheddatafast.m - Displays info used to generate tables in the publication.
publishedfigures.m - Runs code that produces the figures used in the
publication.
****Other scripts****
WARNING: For the complete supplementary info necessary to run these scripts, it
is necessary to email the authors to get additional data (>2GB worth of data).
supplfigures.m - Runs code to generate supplementary info and figures (may take
a while)
publisheddata.m - Same as publisheddatafast.m, except the analysis is actually
performed rather than loading a file containing the results of the analysis
done previously. WARNING: This may take a very, very, long time depending on
your system.
publishedfiguresprep.m - Runs simulation steps to produce
’matfiles/figuredata.mat’, a file used by publishedfigures.m. Not particularly




algorithmparams/ - Contains tables of parameters explored for each algorithm,
as well as the corresponding operating point. Consists of one subdirectory for
each algorithm, with each subdirectory containing one table (csv file) for each
dataset.
data/simulated/ - contains the simulated datasets tested, as downloaded from
http://bioinformatics.mdanderson.org/Supplements/Datasets/Simulations/index.html
discussion/ - Contains written documents supplementing the main content of the
paper.
figures/published/ - where the results of ’publishedfigures.m’ end up... the
reproduced figures from our publication
figures/supplement/ - location of additional figures to compliment those in the
publication.
lib/ - location of code used in benchmarking simulations.
lib/matlab/classes/ - the heart of the code used in benchmarking simulions
(using object-oriented matlab).
lib/matlab/mytools/ - Add’l functions developed for use in benchmarking
simulations (typically not object-oriented).
lib/matlab/scripts/ - Major scripts used to generate results in paper,
illustrating the use of the classes contained in lib/matlab/classes.
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lib/matlab/toolbox/ - location of 3rd party programs used in the benchmarking
simulations. Most of these were downloaded from Matlab Central File Exchange.
matfiles/ - location of .mat files containing simulation info used to construct
publication figures.
---------------------
End Table of Contents
---------------------
A.6 Operating Characteristics
Here we show the mean operating characteristics with standard error bars for each of the
programs tested.
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Figure 23: Operating characteristic: caMassClass
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Figure 24: Operating characteristic: Cromwell
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Figure 25: Operating characteristic: GenePattern
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Figure 26: Operating characteristic: MassSpecWavelet
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Figure 27: Operating characteristic: MeanSpectrum
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Figure 28: Operating characteristic: PPC
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Figure 29: Operating characteristic: PROcess
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Figure 30: Operating characteristic: PROcess/mean spectrum
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Figure 31: Operating characteristic: Ciphergen Express
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APPENDIX B
SUPPLEMENTARY INFORMATION FOR CHAPTER 3:
QUADRATIC VARIANCE MODELS FOR ADAPTIVE
PREPROCESSING OF SELDI MASS SPECTROMETRY DATA
B.1 Reproducible computational research
LibSELDI and the associated MATLAB scripts and data necessary to reproduce the figures
and tables shown in the main text are available for download from the following ftp server:
ftp server: ftp://ftp.vincentemanuele.com/
login and password: Available via email
The files are available in zipped format (Windows users) or tarballs (Unix/Linux users).
Once the files are downloaded, unzip all of the files in the same directory and read the the
provided README.txt and LICENSE.txt files. The software is provided under version 3
of the GNU Public License.
B.2 Relevant SELDI PBS IIc settings
We summarize the machine settings used to generate the buffer+matrix only QA/QC spec-
tra. We have selected what we believe to be the most pertinent factors affecting the results
seen in Fig 8 and 9. The lists in B.2.2 and B.2.3 are a summary of corresponding entries in
the Ciphergen XML files produced. Additional parameters may be read directly out of the
files. The QA/QC procedure used to produce the final BUFFER1 and BUFFER2 datasets
is described in Section B.2.1.
B.2.1 QA/QC (outlier removal)
We examine all spectra generated for BUFFER1 using the quantile spectrum approach
described in the main text. For a fixed t, outlier points are detected as any points falling
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outside the the interval [q25−1.5 ·IQR, q75 +1.5 ·IQR], where q25, q75, and IQR = q75−q25
are the 25% quantile, 75% quantile, and inter-quartile range, respectively. This is done for
all t. Any spectra containing one or more outlier points is declared an outlier and removed.
This QA/QC procedure yields 183 high quality spectra for BUFFER1 and 114 high quality
spectra for BUFFER2.
B.2.2 BUFFER1 settings (202 spectra, pre QA/QC)
• spotProtocolInstructions: Set high mass to 50000 Daltons, optimized from 3000
Daltons to 30000 Daltons. Set starting laser intensity to 185. Set starting detector
sensitivity to 8. Focus by optimization center. Set Mass Deflector to 2000 Daltons.
Set data acquisition method to Seldi Quantitation Set Seldi acquisition parameters
23. delta to 4. transients per to 12 ending position to 83. Set warming positions with
2 shots at intensity 195 and Do not include warming shots. Process sample.
• ionFocusDelay: 9.83e-007 s
• deflectorMass: 2000 Da
• highMassCollected: 50,000 Da




– false (191 spectra)
– true (11 spectra)
B.2.3 BUFFER2 settings (148 spectra, pre QA/QC)
• spotProtocolInstructions:
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• Set high mass to 30000 Daltons, optimized from 3000 Daltons to 30000 Daltons. Set
starting laser intensity to (multiple cases, see below). Set starting detector sensitivity
to 7. Focus by optimization center. Set Mass Deflector to 2500 Daltons. Set data
acquisition method to Seldi Quantitation Set Seldi acquisition parameters 20. delta
to 4. transients per to 12 ending position to 80. Set warming positions with 2 shots
at intensity 220 and Do not include warming shots. Process sample.
• ionFocusDelay: 9.83e-007 s
• deflectorMass: 2500 Da
• highMassCollected: 30,000 Da
• laserIntensityLow: (arbitrary units)
– 185 (46 spectra), 190 (12 spectra), 195 (40 spectra), 200 (26 spectra), 210 (10




– true (148 spectra)
– false (none)
B.3 MassSpecWavelet Code
Below we provide a code snippet to illustrate how MassSpecWavelet was used to calculate
peak/protein predictions for each dataset over a wide range of snr settings in an efficient
way. Note that MassSpecWavelet is implemented in the R computing language.







wCoefs <- cwt( meanInt, scales = scales, wavelet = "mexh" )
print("Analyzing CWT Result\n")
wCoefs <- cbind( as.vector(meanInt), wCoefs)
colnames(wCoefs) <- c(0,scales)
localMax <- getLocalMaximumCWT(wCoefs)
### ...,,, Peak detection steps
print("Looking for peaks/ridges\n")
ridgeList <- getRidge(localMax)
majorPeakInfo <- identifyMajorPeaks( meanInt, ridgeList, wCoefs,
SNR.Th = 1, nearbyPeak=TRUE )
# ...,,, Grab list of potential peaks and their SNRs
potentialPeaks <- majorPeakInfo$potentialPeakIndex
peakSNR <- majorPeakInfo$peakSNR[ names(potentialPeaks) ]
uniqueSNR <- unique( peakSNR )
sortedSNR <-sort( uniqueSNR, decreasing=TRUE )
print("Done\n")
# ... Create data structures for bookeeping




# ...,,, Iterate over all SNRs and produce predictions.
for ( jsnr in 1:length(sortedSNR) ) {
## ... Get peaks with SNR at least this good
thisSNR <- sortedSNR[ jsnr ]
currentIndex <- peakSNR >= thisSNR
currentPeaks <- potentialPeaks[ currentIndex ]
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